Binge-eating disorder: Clinical and therapeutic advances

Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2–5% of the general adult population. Nonetheless, its pathophysiology is poorly understood. Furthermore, there exist few therapeutic options for its effective treatment. Here we review the current state of binge-eat...

Full description

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 182; pp. 15 - 27
Main Authors Hutson, Peter H., Balodis, Iris M., Potenza, Marc N.
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.02.2018
Subjects
Animals
Binge-eating disorder
Binge-Eating Disorder - diagnostic imaging
Binge-Eating Disorder - drug therapy
Binge-Eating Disorder - psychology
Brain - diagnostic imaging
Brain - drug effects
Compulsivity
Disease Models, Animal
Humans
Impulsivity
Neurobiology
Pharmacotherapy
Reward
ADHD
FDA
FAAH
Binge-eating disorder
Neurobiology
MIDT
Pharmacotherapy
CNS
IFG
BN
PFC
OFC
SPECT
YBOCS-BE
DSM 5
NMDA
BOLD
MAGL
BMI
BED
rCBF
LDX
Impulsivity
TRPV
NOP
PPARs
Compulsivity
fMRI
PCC
GMV
SSRI
tDCS
dlPFC
2-AG
CB1 and CB2
PG
GABA
TAAR
OX1 and OX2
Reward
5-HT
PET
Online AccessGet full text

Cover

Abstract Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2–5% of the general adult population. Nonetheless, its pathophysiology is poorly understood. Furthermore, there exist few therapeutic options for its effective treatment. Here we review the current state of binge-eating neurobiology and pharmacology, drawing from clinical therapeutic, neuroimaging, cognitive, human genetic and animal model studies. These studies, which are still in their infancy, indicate that while there are many gaps in our knowledge, several key neural substrates appear to underpin binge-eating and may be conserved between human and animals. This observation suggests that behavioral intermediate phenotypes or endophenotypes relevant to BED may be modeled in animals, facilitating the identification and testing of novel pharmacological targets. The development of novel, safe and effective pharmacological therapies for the treatment of BED will enhance the ability of clinicians to provide optimal care for people with BED.
AbstractList Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2-5% of the general adult population. Nonetheless, its pathophysiology is poorly understood. Furthermore, there exist few therapeutic options for its effective treatment. Here we review the current state of binge-eating neurobiology and pharmacology, drawing from clinical therapeutic, neuroimaging, cognitive, human genetic and animal model studies. These studies, which are still in their infancy, indicate that while there are many gaps in our knowledge, several key neural substrates appear to underpin binge-eating and may be conserved between human and animals. This observation suggests that behavioral intermediate phenotypes or endophenotypes relevant to BED may be modeled in animals, facilitating the identification and testing of novel pharmacological targets. The development of novel, safe and effective pharmacological therapies for the treatment of BED will enhance the ability of clinicians to provide optimal care for people with BED.Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2-5% of the general adult population. Nonetheless, its pathophysiology is poorly understood. Furthermore, there exist few therapeutic options for its effective treatment. Here we review the current state of binge-eating neurobiology and pharmacology, drawing from clinical therapeutic, neuroimaging, cognitive, human genetic and animal model studies. These studies, which are still in their infancy, indicate that while there are many gaps in our knowledge, several key neural substrates appear to underpin binge-eating and may be conserved between human and animals. This observation suggests that behavioral intermediate phenotypes or endophenotypes relevant to BED may be modeled in animals, facilitating the identification and testing of novel pharmacological targets. The development of novel, safe and effective pharmacological therapies for the treatment of BED will enhance the ability of clinicians to provide optimal care for people with BED.
Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2–5% of the general adult population. Nonetheless, its pathophysiology is poorly understood. Furthermore, there exist few therapeutic options for its effective treatment. Here we review the current state of binge-eating neurobiology and pharmacology, drawing from clinical therapeutic, neuroimaging, cognitive, human genetic and animal model studies. These studies, which are still in their infancy, indicate that while there are many gaps in our knowledge, several key neural substrates appear to underpin binge-eating and may be conserved between human and animals. This observation suggests that behavioral intermediate phenotypes or endophenotypes relevant to BED may be modeled in animals, facilitating the identification and testing of novel pharmacological targets. The development of novel, safe and effective pharmacological therapies for the treatment of BED will enhance the ability of clinicians to provide optimal care for people with BED.
Author Potenza, Marc N.
Balodis, Iris M.
Hutson, Peter H.
Author_xml – sequence: 1
  givenname: Peter H.
  surname: Hutson
  fullname: Hutson, Peter H.
  email: peter.hutson@tevapharm.com
  organization: Department of Neurobiology, CNS Discovery, Teva Pharmaceuticals, West Chester, PA, USA
– sequence: 2
  givenname: Iris M.
  surname: Balodis
  fullname: Balodis, Iris M.
  organization: Peter Boris Centre for Addiction Research, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada
– sequence: 3
  givenname: Marc N.
  surname: Potenza
  fullname: Potenza, Marc N.
  organization: Department of Psychiatry, Child Study Center, Yale University School of Medicine, New Haven, CT, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28830840$$D View this record in MEDLINE/PubMed
BookMark eNqNkMtOwzAQRS1URB_wCyhLNgnjxI0dFkhQ8ZIqsQGJneXYE-oqTYqdVuLvcWgrJDawul6cueM5YzJo2gYJiSgkFGh-uUzWC-VW3QKdSlKgPAGRAKRHZEQFL-LAvA3IKEQW83QqhmTs_RIAGIP0hAxTITIQDEZE3NrmHWNUXcjIWN86g-4qmtW2sVrVkWpM9L1njZvO6kiZrWo0-lNyXKna49k-J-T1_u5l9hjPnx-eZjfzWGecdXGOmnJWZBXTJSuESpmuAITR_VNxUZWUVlAKlRsGRWoYz5UGnhXhq2aqaTYhF7vetWs_Nug7ubJeY12rBtuNl7TIKKdZIXr0fI9uyhUauXZ2pdynPFwbgOsdoF3rvcNKatuFy9umc8rWkoLs9cql_NEre70ShAx6Q4H4VXDY8Y_R290oBllbi056bTGYNNah7qRp7d8lX1-dmj0
CitedBy_id crossref_primary_10_1016_j_physbeh_2022_114000
crossref_primary_10_1016_j_pnpbp_2019_109847
crossref_primary_10_1186_s40337_019_0263_1
crossref_primary_10_3389_fpsyg_2024_1343048
crossref_primary_10_1016_j_foodqual_2022_104744
crossref_primary_10_1038_s41380_021_01428_z
crossref_primary_10_1097_FBP_0000000000000496
crossref_primary_10_35414_akufemubid_1451334
crossref_primary_10_1007_s15027_020_2113_0
crossref_primary_10_1016_j_pnpbp_2021_110318
crossref_primary_10_1186_s40337_021_00425_5
crossref_primary_10_2174_1871530322666220627125642
crossref_primary_10_1021_acschemneuro_0c00456
crossref_primary_10_3390_nu15040827
crossref_primary_10_1523_ENEURO_0080_21_2021
crossref_primary_10_1016_j_addicn_2022_100036
crossref_primary_10_1152_physiol_00013_2019
crossref_primary_10_3389_fphar_2018_01424
crossref_primary_10_3390_brainsci8010019
crossref_primary_10_1038_s41562_021_01127_3
crossref_primary_10_1186_s40337_023_00809_9
crossref_primary_10_3389_fnbeh_2019_00027
crossref_primary_10_1016_j_clinthera_2020_10_014
crossref_primary_10_1136_bmjopen_2019_030023
crossref_primary_10_1038_s41386_018_0149_y
crossref_primary_10_1007_s11920_024_01534_z
crossref_primary_10_3390_nu10010071
crossref_primary_10_1080_13543784_2019_1692813
crossref_primary_10_3389_fcomm_2023_1264373
crossref_primary_10_1016_j_pbb_2020_172851
crossref_primary_10_2174_1381612826666200309152321
crossref_primary_10_1016_j_appet_2021_105258
crossref_primary_10_1016_j_appet_2021_105599
crossref_primary_10_1016_j_gene_2021_145538
crossref_primary_10_3389_fphar_2018_00821
crossref_primary_10_1177_03000605231171016
crossref_primary_10_1017_S003329172100475X
crossref_primary_10_3389_fnins_2018_00040
Cites_doi 10.1152/jn.1990.64.4.1055
10.1097/FBP.0b013e328331ba47
10.1007/s00726-010-0659-3
10.1002/hup.899
10.1097/00001756-200408260-00004
10.1016/j.neuropharm.2008.10.005
10.1016/S0306-4522(96)00428-9
10.1111/ejn.12485
10.1016/j.biopsych.2013.09.031
10.1016/j.brainres.2010.04.003
10.1038/npp.2015.275
10.1136/jnnp.2004.048819
10.1002/eat.20541
10.1046/j.0953-816x.2001.01518.x
10.1111/j.1471-4159.2006.03880.x
10.1016/j.appet.2005.09.002
10.1038/npp.2012.89
10.1111/jnc.13157
10.1016/j.pharmthera.2009.07.001
10.1016/j.biopsych.2016.06.005
10.1016/S0167-0115(00)00199-3
10.1002/eat.22204
10.1016/S0306-4522(01)00287-1
10.1124/jpet.115.228221
10.1111/j.1471-4159.1990.tb04599.x
10.1177/0269881117699607
10.1124/jpet.105.084525
10.1016/j.bbr.2016.03.046
10.1016/j.neuropharm.2014.02.014
10.1176/appi.ajp.2007.06121970
10.1016/j.neuroscience.2012.02.036
10.1016/j.appet.2003.08.010
10.1073/pnas.151105198
10.1016/j.biopsych.2013.07.013
10.1002/eat.22114
10.1016/0024-3205(86)90243-2
10.1016/j.biopsych.2006.10.026
10.1212/01.wnl.0000277461.06713.23
10.1038/sj.npp.1301430
10.1093/alcalc/37.5.478
10.1016/S1053-8119(02)00057-5
10.1007/BF03395777
10.1177/0269881117691672
10.1038/nn1181
10.1038/npp.2014.91
10.1016/j.physbeh.2011.10.009
10.1016/0306-4522(92)90409-U
10.1016/j.imbio.2009.09.007
10.1176/appi.ajp.2011.11010094
10.1016/j.biopsych.2007.04.041
10.1037/0735-7044.121.5.877
10.1016/j.pbb.2007.03.004
10.1177/0269881115615107
10.1097/00001756-200111160-00035
10.1007/s11920-016-0696-z
10.1016/j.conb.2012.06.001
10.4088/JCP.v63n1113
10.1007/s00213-016-4329-3
10.1016/0195-6663(90)90014-Y
10.1038/npp.2012.48
10.4088/JCP.v64n0711
10.1016/j.neuroscience.2014.12.046
10.1016/j.neubiorev.2016.03.032
10.1016/S0925-4927(00)00053-6
10.1007/s00213-003-1519-6
10.1038/sj.ijo.0801551
10.1038/mp.2012.154
10.1016/j.bbr.2014.06.049
10.1037/1064-1297.5.3.256
10.1002/syn.1084
10.1124/jpet.111.180943
10.1002/eat.22554
10.1038/oby.2011.24
10.1002/cne.1190
10.1176/ajp.155.12.1756
10.1523/JNEUROSCI.22-09-03306.2002
10.1056/NEJMoa1604221
10.1007/s40263-013-0104-8
10.1210/en.2008-1515
10.1016/j.biopsych.2012.11.020
10.1016/S0306-4522(00)00036-1
10.1016/j.biopsych.2012.10.022
10.1016/j.beproc.2016.08.011
10.1016/S0014-5793(98)01266-6
10.1007/s00737-003-0172-8
10.1016/j.biopsych.2014.08.020
10.1007/s002130100716
10.1016/j.neuroimage.2006.04.216
10.1097/FBP.0000000000000058
10.1016/j.appet.2004.08.001
10.1007/s00213-013-2986-z
10.1523/JNEUROSCI.21-16-j0002.2001
10.1016/j.drugalcdep.2015.10.029
10.1007/s00213-005-2200-z
10.1016/0306-4522(94)00449-F
10.1016/j.euroneuro.2008.05.004
10.1016/S0376-8716(01)00163-6
10.1124/mol.60.6.1181
10.1111/j.1527-3458.2006.00091.x
10.1037/a0013341
10.1016/j.physbeh.2012.06.017
10.1146/annurev.neuro.29.051605.113009
10.1097/00008877-200312000-00002
10.1016/S0014-2999(97)01442-8
10.1016/j.pharmthera.2013.10.011
10.1016/j.physbeh.2005.07.020
10.1016/j.psyneuen.2015.06.018
10.1038/sj.bjp.0705467
10.1038/npp.2014.299
10.1002/erv.2418
10.1038/nn.3449
10.1523/JNEUROSCI.2329-05.2005
10.1016/S0896-6273(01)00303-8
10.1038/sj.npp.1301487
10.3390/nu9030299
10.1002/ajmg.b.30232
10.1523/JNEUROSCI.23-07-02882.2003
10.1037/0033-2909.110.1.86
10.1126/science.1121218
10.1097/FBP.0b013e328357bd62
10.1523/JNEUROSCI.18-23-09996.1998
10.1038/oby.2009.52
10.1046/j.1460-9568.2000.00217.x
10.1177/0269881116647506
10.1523/JNEUROSCI.2050-10.2011
10.1016/j.tips.2011.03.007
10.1016/j.pneurobio.2004.03.006
10.1016/S0022-3565(25)13057-7
10.4088/JCP.v68n0306
10.1007/s00213-009-1558-8
10.1016/j.neuroimage.2004.08.023
10.1017/S1092852915000814
10.1016/j.biopsych.2013.01.014
10.1002/oby.20068
10.1073/pnas.1315542111
10.1038/oby.2010.46
10.1038/npp.2016.264
10.1016/j.neubiorev.2016.01.013
10.1016/j.biopsych.2008.09.028
10.1016/S0014-2999(01)00968-2
10.1016/j.pbb.2009.02.002
10.1016/j.bmcl.2009.02.078
10.1111/adb.12056
10.1038/nrn3504
10.1111/adb.12065
10.1016/j.pharmthera.2014.03.005
10.1038/npp.2016.265
10.1038/bjp.2008.3
10.1111/j.1471-4159.2012.07649.x
10.1038/ijo.2009.221
10.1111/bph.12014
10.1586/ern.11.175
10.1016/j.psychres.2012.10.016
10.1016/j.neuropharm.2014.09.025
10.1007/s00213-012-2778-x
10.1038/npp.2012.128
10.1038/sj.ijo.0801949
10.1177/1073858404263526
10.1016/j.neuroimage.2009.12.063
10.1007/s00213-006-0578-x
10.1001/archpsyc.57.7.659
10.1007/s00213-008-1442-y
10.1016/S0028-3908(01)00063-6
10.1016/j.peptides.2005.03.042
10.1002/hbm.21345
10.1038/365061a0
10.1098/rstb.2012.0380
10.1093/scan/nsw049
10.1111/adb.12033
10.1002/eat.20434
10.1124/jpet.107.132647
10.1016/j.biopsych.2013.09.005
10.3945/ajcn.2009.27924
10.1016/j.pnpbp.2008.06.005
10.1021/acs.jmedchem.6b00538
10.1016/S0140-6736(06)69571-8
10.1038/oby.2011.27
10.1002/eat.20869
10.1016/j.neuropharm.2011.05.034
10.1001/archgenpsychiatry.2008.504
10.1017/S1092852915000681
ContentType Journal Article
Copyright 2017 Elsevier Inc.
Copyright © 2017 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Inc.
– notice: Copyright © 2017 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.pharmthera.2017.08.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-016X
EndPage 27
ExternalDocumentID 28830840
10_1016_j_pharmthera_2017_08_002
S0163725817302127
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29O
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
WUQ
Y6R
ZGI
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
EFKBS
CGR
CUY
CVF
ECM
EIF
NPM
SSH
7X8
ID FETCH-LOGICAL-c374t-6ec17493f4cb498a24cf008dc8a24a78fb11f0b8a6d4092d476ac0739044d5c13
IEDL.DBID .~1
ISSN 0163-7258
1879-016X
IngestDate Mon Jul 21 11:05:56 EDT 2025
Thu Apr 03 07:08:33 EDT 2025
Thu Apr 24 22:57:02 EDT 2025
Tue Aug 05 12:07:04 EDT 2025
Fri Feb 23 02:15:39 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords ADHD
FDA
FAAH
Binge-eating disorder
Neurobiology
MIDT
Pharmacotherapy
CNS
IFG
BN
PFC
OFC
SPECT
YBOCS-BE
DSM 5
NMDA
BOLD
MAGL
BMI
BED
rCBF
LDX
Impulsivity
TRPV
NOP
PPARs
Compulsivity
fMRI
PCC
GMV
SSRI
tDCS
dlPFC
2-AG
CB1 and CB2
PG
GABA
TAAR
OX1 and OX2
Reward
5-HT
PET
Language English
License Copyright © 2017 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c374t-6ec17493f4cb498a24cf008dc8a24a78fb11f0b8a6d4092d476ac0739044d5c13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 28830840
PQID 1931713981
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_1931713981
pubmed_primary_28830840
crossref_citationtrail_10_1016_j_pharmthera_2017_08_002
crossref_primary_10_1016_j_pharmthera_2017_08_002
elsevier_sciencedirect_doi_10_1016_j_pharmthera_2017_08_002
PublicationCentury 2000
PublicationDate February 2018
2018-02-00
20180201
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: February 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmacology & therapeutics (Oxford)
PublicationTitleAlternate Pharmacol Ther
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References McLaughlin, Winston, Swezey, Wisniecki, Aberman, Tardif, Salamone (bb0595) 2003; 14
Solinas, Justinova, Goldberg, Tanda (bb0780) 2006; 98
Czyzyk, Sahr, Statnick (bb0225) 2010; 18
Corwin, Boan, Peters, Ulbrecht (bb0195) 2012; 23
Geliebter, Ladell, Logan, Schneider, Sharafi, Hirsch (bb0280) 2006; 46
Arnold, McElroy, Hudson, Welge, Bennett, Keck (bb0015) 2002; 63
Sagheddu, Muntoni, Pistis, Melis (bb0730) 2015; 125
Porubská, Veit, Preissl, Fritsche, Birbaumer (bb0685) 2006; 3
Cousins, Roberts, de Wit (bb0210) 2002; 65
Robinson, Eagle, Mar, Bari, Banerjee, Jiang, Robbins (bb0700) 2008; 33
Breiter, Aharon, Kahneman, Dale, Shizgal (bb0105) 2001; 30
Edwards, Abizaid (bb0255) 2016; 66
Liu, Chen, Lerner, Brackett, Matsumoto (bb0500) 2005; 314
Voon (bb0855) 2015; 20
Majuri, Joutsa, Johansson, Voon, Alakurtti, Parkkola, Kaasinen (bb0520) 2016; 42
Hudson, McElroy, Raymond, Crow, Keck, Carter, Jonas (bb0380) 1998; 155
Peyron, Tighe, van den Pol, de Lecea, Heller, Sutcliffe, Kilduff (bb0670) 1998; 18
Brody, Mandelkern, Olmstead, Jou, Tiongson, Allen, Cohen (bb0110) 2007; 62
Sidhpura, Parsons (bb0765) 2011; 61
Choi, Davis, Magrisso, Fitzgerald, Lipton, Benoit (bb0175) 2012; 210
Kuikka, Tammela, Karhunen, Rissanen, Bergstrom, Naukkarinen, Uusitupa (bb0470) 2001; 155
Pattij, Schetters, Janssen, Wiskerke, Schoffelmeer (bb0650) 2009; 205
Kerbrat, Ferré, Fillatre, Ronzière, Vannier, Carsin-Nicol, Edan (bb0425) 2016; 375
O'Sullivan, Kendall (bb0625) 2010; 215
McElroy, Hudson, Ferreira-Cornwell, Radewonuk, Whitaker, Gasior (bb0580) 2016; 4
Palavras, Hay, Filho, Claudino (bb0630) 2017; 9
Hutson, Tarazi, Madhoo, Slawecki, Patkar (bb0395) 2014; 143
McElroy, Mitchell, Wilfley, Gasior, Ferreira-Cornwell, McKay, Hudson (bb0590) 2016; 24
Trivedi, Yu, MacNeil, Van der Ploeg, Guan (bb0810) 1998; 438
Mena, Sadeghian, Baldo (bb0600) 2011; 31
Marsh, Horga, Wang, Wang, Klahr, Berner, Peterson (bb0535) 2011; 168
Carai, Colombo, Maccioni, Gessa (bb0150) 2006; 12
Wilfley, Crow, Hudson, Mitchell, Berkowitz, Blakesley, Walsh (bb0900) 2008; 165
Leombruni, Pierò, Lavagnino, Brustolin, Campisi, Fassino (bb0480) 2008; 32
Madden, Petry, Badger, Bickel (bb0510) 1997; 5
McElroy, Hudson, Malhotra, Welge, Nelson, Keck (bb0585) 2003; 64
Colantuoni, Schwenker, McCarthy, Rada, Ladenheim, Cadet, Hoebel (bb0185) 2001; 12
Kessler, Berglund, Chiu, Deitz, Hudson, Shahly, Xavier (bb0430) 2013; 73
Hyman, Malenka, Nestler (bb0400) 2006; 29
Giuliano, Robbins, Nathan, Bullmore, Everitt (bb0290) 2012; 37
Fairburn, Cooper, Doll, Norman, O'Connor (bb0265) 2000; 57
Karhunen, Vanninen, Kuikka, Lappalainen, Tiihonen, Uusitupa (bb0415) 2000; 99
Goldschmidt, Le Grange, Powers, Crow, Hill, Peterson, Mitchell (bb0300) 2011; 19
Mailleux, Vanderhaeghen (bb0515) 1992; 48
Berner, Bocarsly, Hoebel, Avena (bb0050) 2009; 20
Nair, Golden, Shaham (bb0620) 2008; 154
Marcus, Aschkenasi, Lee, Chemelli, Saper, Yanagisawa, Elmquist (bb0530) 2001; 435
Levy, Glimcher (bb0485) 2012; 22
Simon, Skunde, Walther, Bendszus, Herzog, Friederich (bb0770) 2016; 11
Hernandez, Oleson, Gentry, Abbas, Bernstein, Arvanitogiannis, Cheer (bb0365) 2014; 75
Epstein, Temple, Neaderhiser, Salis, Erbe, Leddy (bb0260) 2007; 121
Staley, Krishnan-Sarin, Zoghbi, Tamagnan, Fujita, Seibyl, Innis (bb0785) 2001; 41
Knutson, Fong, Bennett, Adams, Hommer (bb0455) 2003; 18
Vickers, Hackett, Murray, Hutson, Heal (bb0850) 2015; 29
Brebner, Childress, Roberts (bb0100) 2002; 37
Knutson, Adams, Fong, Hommer (bb0450) 2001; 21
Hayes, Jupp, Sawiak, Merlo, Caprioli, Dalley (bb0335) 2014; 39
Leggio, Cathala, Moison, Cunningham, Piazza, Spampinato (bb0475) 2009; 56
Bisaga, Danysz, Richard, Foltin (bb0070) 2008; 18
Koblan, Hopkins, Sarma, Gallina, Jin, Levy-Cooperman, Loebel (bb0460) 2016; 159
Balodis, Molina, Kober, Worhunsky, White, Sinha, Potenza (bb0035) 2013; 2
Chamberlain, Mogg, Bradley, Koch, Dodds, Tao, Nathan (bb0160) 2012; 224
Baylis, Rolls, Baylis (bb0045) 1995; 64
Heal, Goddard, Brammer, Hutson, Vickers (bb0345) 2016; 30
Kew, Kemp (bb0440) 2005; 179
Rodgers, Halford, Nunes de Souza, Canto de Souza, Piper, Arch, Blundell (bb0705) 2001; 13
Matsumoto, McCracken, Friedman, Pouw, De Costa, Bowen (bb0545) 2001; 419
Parylak, Cottone, Sabinoa, Rice, Zorrilla (bb0640) 2012; 107
Dingemans, Bruna, van Furth (bb0240) 2002; 26
Dittmann, Cardo, Nagy, Anderson, Bloomfield, Caballero, Coghill (bb0245) 2013; 27
Xu, He, Cao, Valencia-Torres, Yan, Saito, Xu (bb0935) 2016; 81
Hess, Hess, Meyer, Verhagen, Koch, Brönneke, Brüning (bb0370) 2013; 16
Thorn, Jing, Qiu, Gancarz-Kausch, Galuska, Dietz, Li (bb0805) 2014; 39
Alcaraz-Iborraa, Carvajalb, Lerma-Cabrerab, Valorc, Cuberoa (bb0005) 2014; 272
Kalivas, Duffy, Eberhardt (bb0410) 1990; 253
Weisler, Adler, Kollins, Goodman, Hamdani, Dirks, Childress (bb0875) 2014; 10
Szabo, Wallmichrath, Mathonia, Pfreundtner (bb0795) 2000; 97
Rolls, Yaxley, Sienkiewicz (bb0715) 1990; 64
White, Ishii, Mendozaa, Upton, Stasi, Bray, York (bb0895) 2005; 26
Ansquer, Belin-Rauscent, Dugast, Duran, Benatru, Mar, Belin (bb0010) 2014; 75
Davis, Levitan, Reid, Carter, Kaplan, Patte, Kennedy (bb0235) 2009; 17
Guerdjikova, McElroy, Kotwal, Welge, Nelson, Lake, Hudson (bb0315) 2008; 23
Lindemann, Meyer, Jeanneau, Bradaia, Ozmen, Bluethmann, Hoener (bb0490) 2008; 324
Balodis, Grilo, Kober, Worhunsky, White, Stevens, Potenza (bb0020) 2014; 47
Ziauddeen, Chamberlain, Nathan, Koch, Maltby, Bush, Bullmore (bb0940) 2013; 18
Bohon, Stice (bb0080) 2011; 44
Westenhoefer, Pudel, Maus (bb0885) 1990; 14
Wong, Wojnicki, Corwin (bb0925) 2009; 92
Sharman, Pennick (bb0760) 2014; 10
Weygandt, Schaefer, Schienle, Haynes (bb0890) 2012; 33
Liu, Borgland (bb0495) 2015; 289
Grilo, Reas, Mitchell (bb0310) 2016; 18
Piccoli, Di Bonaventura, Cifani, Costantini, Massagrande, Montanari, Corsi (bb0675) 2012; 37
Corwin (bb0190) 2004; 42
Dore, Valenza, Wang, Rice, Sabino, Cottone (bb0250) 2014; 19
Heatherton, Baumeister (bb0360) 1991; 110
Hutson, Heins, Folgering (bb0385) 2015; 134
McElroy, Guerdjikova, Blom, Crow, Memisoglu, Silverman, L., & Ehrich, E. W. (bb0570) 2013; 46
Balodis, Grilo, Potenza (bb0025) 2015; 20
Scherma, Fattore, Satta, Businco, Pigliacampo, Goldberg, Fadda (bb0750) 2013; 169
Marsh, Steinglass, Gerber, Graziano O'Leary, Wang, Murphy, Peterson (bb0540) 2009; 1
Burgess, Sylvester, Morse, Amthor, Mrug, Lokken, Boggiano (bb0130) 2016; 49
Childress, Sallee (bb0170) 2012; 12
Schienle, Schafer, Hermann, Vaitl (bb0755) 2009; 65
Born, Lemmens, Rutters, Nieuwenhuizen, Formisano, Goebel, Westerterp-Plantenga (bb0090) 2010; 34
Rossetti, Spena, Halfon, Boutrel (bb0725) 2014; 19
Woolley, Gorno-Tempini, Seeley, Rankin, Lee, Matthews, Miller (bb0930) 2007; 69
Cruz, Ivanova, Lunn, Stoffel, Slesinger, Lüscher (bb0215) 2004; 7
Will, Franzblau, Kelley (bb0910) 2004; 15
Bevilacqua, Goldman (bb0065) 2013; 368
Carboni, Tanda, Frau, Di Chiara (bb0155) 1990; 55
Hutson, Pennick, Secker (bb0390) 2014; 87
Manwaring, Green, Myerson, Strube, Wilfley (bb0525) 2011; 61
Vickers, Goddard, Brammer, Hutson, Heal (bb0845) 2017; 31
Schäfer, Vaitl, Schienle (bb0740) 2010; 50
Klatzkin, Gaffney, Cyrus, Bigus, Brownley (bb0445) 2016, Nov 9
Hajos, Katona, Naiem, MacKie, Ledent, Mody, Freund (bb0320) 2000; 12
Heal, Smith, Henningfield (bb0355) 2014; 87
Berridge, Ho, Richard, DiFeliceantonio (bb0060) 2010; 1350
Cottone, Sabino, Steardo, Zorrilla (bb0200) 2008; 33
Heal, Hallam, Prow, Gosden, Cheetham, Choi, Hutson (bb0350) 2017; 31
Sakurai, Mieda (bb0735) 2011; 32
Balodis, Potenza (bb0040) 2015; 77
Vickers, Dourish, Kennett (bb0840) 2001; 41
Haynes, Jackson, Chapman, Tadayyon, Johns, Porter, Arch (bb0340) 2000; 96
Kessler, Hutson, Herman, Potenza (bb0435) 2016; 63
Pruessner, Dedovic, Khalili-Mahani, Engert, Pruessner, Buss, Lupien (bb0690) 2008; 63
Paoletti, Bellone, Zhou (bb0635) 2013; 14
Popik, Kos, Zhang, Bisaga (bb0680) 2011; 40
Monteleone, Tortorella, Castaldo, Maj (bb0605) 2006; 141B
Wang, Geliebter, Volkow, Telang, Logan, Jayne, Fowler (bb0865) 2011; 19
Borowsky, Adham, Jones, Raddatz, Artymyshyn, Ogozalek, Gerald (bb0095) 2001; 98
McElroy, Guerdjikova, Kotwal, Welge, Nelson, Lake, Hudson (bb0575) 2007; 68
Gosnell, Levine, Morley (bb0305) 1986; 38
Muschamp, Hollande, Thompson, Voren, Hassinger, Onvani, Carlezon (bb0615) 2014; 111
Rasmussen, Reilly, Buckley, Boomhower (bb0695) 2012; 105
Peciña, Berridge (bb0660) 2005; 25
Cyders, Smith (bb0220) 2008; 134
Pearlstein, Spurell, Hohlstein, Gurney, Read, Fuchs, Keller (bb0655) 2003; 6
Roefs, Herman, Macleod, Smulders, Jansen (bb0710) 2005; 44
Kelley, Berridge (bb0420) 2002; 22
Ignar, Goetz, Nichols Noble, Carballo, Stroup, Fisher, Hommel (bb0405) 2011; 339
Valdivia, Cornejo, Reynaldo, De Francesco, Perello (bb0830) 2015; 60
Womble, Williamson, Greenway, Redmann (bb0920) 2001; 25
Caprioli, Sawiak, Merlo, Theobald, Spoelder, Jupp, Dalley (bb0145) 2014; 15
Uher, Treasure (bb0820) 2005; 76
Pelchat, Johnson, Chan, Valdez, Ragland (bb0665) 2004; 23
Statnick, Chen, Ansonoff, Witkin, Rorick-Kehn, Suter, Pintar (bb2000) 2016; 356
Boomhower, Rasmussen (bb0085) 2014; 25
Bunzow, Sonders, Arttamangkul, Harrison, Zhang, Quigley, Grandy (bb0125) 2001; 60
Tammela, Rissanen, Kuikka, Karhunen, Bergström, Repo-Tiihonen, Uusitupa (bb0800) 2003; 170
Will, Franzblau, Kelley (bb0905) 2003; 23
Scheen, Finer, Hollander, Jensen, Van Gaal, RIO-Diabetes Study Group (bb0745) 2006; 368
Lyu, Jackson (bb0505) 2016; 13
Hajos, Ledent, Freund (bb0325) 2001; 106
Upadhyaya, Desaiah, Schuh, Bymaster, Kallman, Clarke, Allen (bb0825) 2013; 226
Witkin, Statnick, Rorick-Kehn, Pintar, Ansonoff, Chen, Ciccocioppo (bb0915) 2014; 141
Buda-Levin, Wojnicki, Corwin (bb0120) 2005; 86
Pataky, Gasteyger, Ziegler, Rissanen, Hanotin, Golay (bb0645) 2013; 121
Danner, Evers, Sternheim, Meer, van Elburg, Geerets, de Ridder (bb0230) 2013; 207
Valencia-Torres, Olarte-Sánchez, Lyons, Georgescu, Greenwald-Yarnell, Myers, Heisler (bb0835) 2016; 42
Cifani, Polidori, Melotto, Ciccocioppo, Massi (bb0180) 2009; 204
Cambridge, Ziauddeen, Nathan, Subramaniam, Dodds, Chamberlain, Fletcher (bb0135) 2013; 73
Tuo, Leleu-Chavain, Spencer, Sansook, Millet, Chavatte (bb0815) 2017; 60
Vucetic, Carlin, Totoki, Reyes (bb0860) 2012; 120
Gessa, Melis, Muntoni, Diana (bb0285) 1
Berridge (10.1016/j.pharmthera.2017.08.002_bb0060) 2010; 1350
Bunzow (10.1016/j.pharmthera.2017.08.002_bb0125) 2001; 60
Dittmann (10.1016/j.pharmthera.2017.08.002_bb0245) 2013; 27
Pearlstein (10.1016/j.pharmthera.2017.08.002_bb0655) 2003; 6
Weisler (10.1016/j.pharmthera.2017.08.002_bb0875) 2014; 10
Breiter (10.1016/j.pharmthera.2017.08.002_bb0105) 2001; 30
Solinas (10.1016/j.pharmthera.2017.08.002_bb0780) 2006; 98
Cyders (10.1016/j.pharmthera.2017.08.002_bb0220) 2008; 134
Roefs (10.1016/j.pharmthera.2017.08.002_bb0710) 2005; 44
Arnold (10.1016/j.pharmthera.2017.08.002_bb0015) 2002; 63
Balodis (10.1016/j.pharmthera.2017.08.002_bb0040) 2015; 77
Will (10.1016/j.pharmthera.2017.08.002_bb0910) 2004; 15
Cambridge (10.1016/j.pharmthera.2017.08.002_bb0135) 2013; 73
Rolls (10.1016/j.pharmthera.2017.08.002_bb0715) 1990; 64
Leombruni (10.1016/j.pharmthera.2017.08.002_bb0480) 2008; 32
Simon (10.1016/j.pharmthera.2017.08.002_bb0770) 2016; 11
Wang (10.1016/j.pharmthera.2017.08.002_bb0865) 2011; 19
Muschamp (10.1016/j.pharmthera.2017.08.002_bb0615) 2014; 111
Tuo (10.1016/j.pharmthera.2017.08.002_bb0815) 2017; 60
Caprioli (10.1016/j.pharmthera.2017.08.002_bb0145) 2014; 15
Buda-Levin (10.1016/j.pharmthera.2017.08.002_bb0120) 2005; 86
Carai (10.1016/j.pharmthera.2017.08.002_bb0150) 2006; 12
Brody (10.1016/j.pharmthera.2017.08.002_bb0110) 2007; 62
Klatzkin (10.1016/j.pharmthera.2017.08.002_bb0445) 2016
Madden (10.1016/j.pharmthera.2017.08.002_bb0510) 1997; 5
Dore (10.1016/j.pharmthera.2017.08.002_bb0250) 2014; 19
Giuliano (10.1016/j.pharmthera.2017.08.002_bb0290) 2012; 37
Vucetic (10.1016/j.pharmthera.2017.08.002_bb0860) 2012; 120
Balodis (10.1016/j.pharmthera.2017.08.002_bb0035) 2013; 2
Grilo (10.1016/j.pharmthera.2017.08.002_bb0310) 2016; 18
Xu (10.1016/j.pharmthera.2017.08.002_bb0935) 2016; 81
Higgins (10.1016/j.pharmthera.2017.08.002_bb0375) 2016; 233
Liu (10.1016/j.pharmthera.2017.08.002_bb0500) 2005; 314
Choi (10.1016/j.pharmthera.2017.08.002_bb0175) 2012; 210
Born (10.1016/j.pharmthera.2017.08.002_bb0090) 2010; 34
Smith (10.1016/j.pharmthera.2017.08.002_bb0775) 2015; 40
Wilfley (10.1016/j.pharmthera.2017.08.002_bb0900) 2008; 165
Knutson (10.1016/j.pharmthera.2017.08.002_bb0455) 2003; 18
Lindemann (10.1016/j.pharmthera.2017.08.002_bb0490) 2008; 324
Porubská (10.1016/j.pharmthera.2017.08.002_bb0685) 2006; 3
Sagheddu (10.1016/j.pharmthera.2017.08.002_bb0730) 2015; 125
Hess (10.1016/j.pharmthera.2017.08.002_bb0370) 2013; 16
Matsumoto (10.1016/j.pharmthera.2017.08.002_bb0545) 2001; 419
Schienle (10.1016/j.pharmthera.2017.08.002_bb0755) 2009; 65
Bisaga (10.1016/j.pharmthera.2017.08.002_bb0070) 2008; 18
Chamberlain (10.1016/j.pharmthera.2017.08.002_bb0160) 2012; 224
Glass (10.1016/j.pharmthera.2017.08.002_bb0295) 1997; 77
Broft (10.1016/j.pharmthera.2017.08.002_bb0115) 2007; 40
Tammela (10.1016/j.pharmthera.2017.08.002_bb0800) 2003; 170
Balodis (10.1016/j.pharmthera.2017.08.002_bb0025) 2015; 20
Pelchat (10.1016/j.pharmthera.2017.08.002_bb0665) 2004; 23
Kelley (10.1016/j.pharmthera.2017.08.002_bb0420) 2002; 22
Peyron (10.1016/j.pharmthera.2017.08.002_bb0670) 1998; 18
Marcus (10.1016/j.pharmthera.2017.08.002_bb0530) 2001; 435
Foltin (10.1016/j.pharmthera.2017.08.002_bb0275) 2007; 86
Marsh (10.1016/j.pharmthera.2017.08.002_bb0535) 2011; 168
Upadhyaya (10.1016/j.pharmthera.2017.08.002_bb0825) 2013; 226
Corwin (10.1016/j.pharmthera.2017.08.002_bb0190) 2004; 42
Weygandt (10.1016/j.pharmthera.2017.08.002_bb0890) 2012; 33
Ziauddeen (10.1016/j.pharmthera.2017.08.002_bb0940) 2013; 18
Kringelbach (10.1016/j.pharmthera.2017.08.002_bb0465) 2004; 72
Majuri (10.1016/j.pharmthera.2017.08.002_bb0520) 2016; 42
Statnick (10.1016/j.pharmthera.2017.08.002_bb2000) 2016; 356
Borowsky (10.1016/j.pharmthera.2017.08.002_bb0095) 2001; 98
Maurice (10.1016/j.pharmthera.2017.08.002_bb0555) 2009; 124
Sidhpura (10.1016/j.pharmthera.2017.08.002_bb0765) 2011; 61
Wentland (10.1016/j.pharmthera.2017.08.002_bb0880) 2009; 19
Childress (10.1016/j.pharmthera.2017.08.002_bb0170) 2012; 12
Hyman (10.1016/j.pharmthera.2017.08.002_bb0400) 2006; 29
Hutson (10.1016/j.pharmthera.2017.08.002_bb0395) 2014; 143
Cousins (10.1016/j.pharmthera.2017.08.002_bb0210) 2002; 65
Szabo (10.1016/j.pharmthera.2017.08.002_bb0795) 2000; 97
Ross (10.1016/j.pharmthera.2017.08.002_bb0720) 2003; 140
Hardaway (10.1016/j.pharmthera.2017.08.002_bb0330) 2016; 307
Corwin (10.1016/j.pharmthera.2017.08.002_bb0195) 2012; 23
Goldschmidt (10.1016/j.pharmthera.2017.08.002_bb0300) 2011; 19
Vickers (10.1016/j.pharmthera.2017.08.002_bb0850) 2015; 29
Koblan (10.1016/j.pharmthera.2017.08.002_bb0460) 2016; 159
Gessa (10.1016/j.pharmthera.2017.08.002_bb0285) 1998; 341
Heal (10.1016/j.pharmthera.2017.08.002_bb0345) 2016; 30
Geliebter (10.1016/j.pharmthera.2017.08.002_bb0280) 2006; 46
Epstein (10.1016/j.pharmthera.2017.08.002_bb0260) 2007; 121
McLaughlin (10.1016/j.pharmthera.2017.08.002_bb0595) 2003; 14
Bevilacqua (10.1016/j.pharmthera.2017.08.002_bb0065) 2013; 368
McElroy (10.1016/j.pharmthera.2017.08.002_bb0570) 2013; 46
Scherma (10.1016/j.pharmthera.2017.08.002_bb0750) 2013; 169
Fairburn (10.1016/j.pharmthera.2017.08.002_bb0265) 2000; 57
Liu (10.1016/j.pharmthera.2017.08.002_bb0495) 2015; 289
Pattij (10.1016/j.pharmthera.2017.08.002_bb0650) 2009; 205
Hernandez (10.1016/j.pharmthera.2017.08.002_bb0365) 2014; 75
Colantuoni (10.1016/j.pharmthera.2017.08.002_bb0185) 2001; 12
Davis (10.1016/j.pharmthera.2017.08.002_bb0235) 2009; 17
Cifani (10.1016/j.pharmthera.2017.08.002_bb0180) 2009; 204
Levy (10.1016/j.pharmthera.2017.08.002_bb0485) 2012; 22
Guerdjikova (10.1016/j.pharmthera.2017.08.002_bb0315) 2008; 23
Leggio (10.1016/j.pharmthera.2017.08.002_bb0475) 2009; 56
McClure (10.1016/j.pharmthera.2017.08.002_bb0565) 2004; 10
Pruessner (10.1016/j.pharmthera.2017.08.002_bb0690) 2008; 63
Haynes (10.1016/j.pharmthera.2017.08.002_bb0340) 2000; 96
Berner (10.1016/j.pharmthera.2017.08.002_bb0050) 2009; 20
Woolley (10.1016/j.pharmthera.2017.08.002_bb0930) 2007; 69
McElroy (10.1016/j.pharmthera.2017.08.002_bb0585) 2003; 64
Brennan (10.1016/j.pharmthera.2017.08.002_bb3000) 2008; 41
Schäfer (10.1016/j.pharmthera.2017.08.002_bb0740) 2010; 50
Valdivia (10.1016/j.pharmthera.2017.08.002_bb0830) 2015; 60
Hutson (10.1016/j.pharmthera.2017.08.002_bb0385) 2015; 134
Hajos (10.1016/j.pharmthera.2017.08.002_bb0320) 2000; 12
Hajos (10.1016/j.pharmthera.2017.08.002_bb0325) 2001; 106
Vickers (10.1016/j.pharmthera.2017.08.002_bb0840) 2001; 41
Staley (10.1016/j.pharmthera.2017.08.002_bb0785) 2001; 41
O'Sullivan (10.1016/j.pharmthera.2017.08.002_bb0625) 2010; 215
Scheen (10.1016/j.pharmthera.2017.08.002_bb0745) 2006; 368
Alcaraz-Iborraa (10.1016/j.pharmthera.2017.08.002_bb0005) 2014; 272
Kuikka (10.1016/j.pharmthera.2017.08.002_bb0470) 2001; 155
Mailleux (10.1016/j.pharmthera.2017.08.002_bb0515) 1992; 48
Hayes (10.1016/j.pharmthera.2017.08.002_bb0335) 2014; 39
Lyu (10.1016/j.pharmthera.2017.08.002_bb0505) 2016; 13
Marsh (10.1016/j.pharmthera.2017.08.002_bb0540) 2009; 1
Boomhower (10.1016/j.pharmthera.2017.08.002_bb0085) 2014; 25
Dingemans (10.1016/j.pharmthera.2017.08.002_bb0240) 2002; 26
Womble (10.1016/j.pharmthera.2017.08.002_bb0920) 2001; 25
McElroy (10.1016/j.pharmthera.2017.08.002_bb0575) 2007; 68
Cottone (10.1016/j.pharmthera.2017.08.002_bb0205) 2012; 37
Peciña (10.1016/j.pharmthera.2017.08.002_bb0660) 2005; 25
Chamberlain (10.1016/j.pharmthera.2017.08.002_bb0165) 2006; 311
Nair (10.1016/j.pharmthera.2017.08.002_bb0620) 2008; 154
Ansquer (10.1016/j.pharmthera.2017.08.002_bb0010) 2014; 75
Sharman (10.1016/j.pharmthera.2017.08.002_bb0760) 2014; 10
Cruz (10.1016/j.pharmthera.2017.08.002_bb0215) 2004; 7
Cano (10.1016/j.pharmthera.2017.08.002_bb0140) 2016; 132
Kessler (10.1016/j.pharmthera.2017.08.002_bb0430) 2013; 73
Mena (10.1016/j.pharmthera.2017.08.002_bb0600) 2011; 31
Burgess (10.1016/j.pharmthera.2017.08.002_bb0130) 2016; 49
Brebner (10.1016/j.pharmthera.2017.08.002_bb0100) 2002; 37
Matsushita (10.1016/j.pharmthera.2017.08.002_bb0550) 2009; 150
Rodgers (10.1016/j.pharmthera.2017.08.002_bb0705) 2001; 13
Uher (10.1016/j.pharmthera.2017.08.002_bb0820) 2005; 76
Hutson (10.1016/j.pharmthera.2017.08.002_bb0390) 2014; 87
Parylak (10.1016/j.pharmthera.2017.08.002_bb0640) 2012; 107
Balodis (10.1016/j.pharmthera.2017.08.002_bb0020) 2014; 47
Popik (10.1016/j.pharmthera.2017.08.002_bb0680) 2011; 40
Valencia-Torres (10.1016/j.pharmthera.2017.08.002_bb0835) 2016; 42
Statnick (10.1016/j.pharmthera.2017.08.002_bb0790) 2014; 39
Piccoli (10.1016/j.pharmthera.2017.08.002_bb0675) 2012; 37
Robinson (10.1016/j.pharmthera.2017.08.002_bb0700) 2008; 33
Pataky (10.1016/j.pharmthera.2017.08.002_bb0645) 2013; 121
Heal (10.1016/j.pharmthera.2017.08.002_bb0350) 2017; 31
Knutson (10.1016/j.pharmthera.2017.08.002_bb0450) 2001; 21
Ignar (10.1016/j.pharmthera.2017.08.002_bb0405) 2011; 339
White (10.1016/j.pharmthera.2017.08.002_bb0895) 2005; 26
Munro (10.1016/j.pharmthera.2017.08.002_bb0610) 1993; 365
Bohon (10.1016/j.pharmthera.2017.08.002_bb0080) 2011; 44
Balodis (10.1016/j.pharmthera.2017.08.002_bb0030) 2013; 73
Vickers (10.1016/j.pharmthera.2017.08.002_bb0845) 2017; 31
Czyzyk (10.1016/j.pharmthera.2017.08.002_bb0225) 2010; 18
Cottone (10.1016/j.pharmthera.2017.08.002_bb0200) 2008; 33
Will (10.1016/j.pharmthera.2017.08.002_bb0905) 2003; 23
McElroy (10.1016/j.pharmthera.2017.08.002_bb0580) 2016; 4
Ferragud (10.1016/j.pharmthera.2017.08.002_bb0270) 2016
Rasmussen (10.1016/j.pharmthera.2017.08.002_bb0695) 2012; 105
McElroy (10.1016/j.pharmthera.2017.08.002_bb0590) 2016; 24
Palavras (10.1016/j.pharmthera.2017.08.002_bb0630) 2017; 9
Westenhoefer (10.1016/j.pharmthera.2017.08.002_bb0885) 1990; 14
Monteleone (10.1016/j.pharmthera.2017.08.002_bb0605) 2006; 141B
Paoletti (10.1016/j.pharmthera.2017.08.002_bb0635) 2013; 14
Trivedi (10.1016/j.pharmthera.2017.08.002_bb0810) 1998; 438
Wong (10.1016/j.pharmthera.2017.08.002_bb0925) 2009; 92
Gosnell (10.1016/j.pharmthera.2017.08.002_bb0305) 1986; 38
Karhunen (10.1016/j.pharmthera.2017.08.002_bb0415) 2000; 99
Hudson (10.1016/j.pharmthera.2017.08.002_bb0380) 1998; 155
Witkin (10.1016/j.pharmthera.2017.08.002_bb0915) 2014; 141
Kessler (10.1016/j.pharmthera.2017.08.002_bb0435) 2016; 63
Carboni (10.1016/j.phar
References_xml – volume: 33
  start-page: 524
  year: 2008
  end-page: 535
  ident: bb0200
  article-title: Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food
  publication-title: Neuropsychopharmacology
– volume: 39
  start-page: 1921
  year: 2014
  end-page: 1932
  ident: bb0335
  article-title: Brain γ-aminobutyric acid: A neglected role in impulsivity
  publication-title: The European Journal of Neuroscience
– volume: 179
  start-page: 4
  year: 2005
  end-page: 29
  ident: bb0440
  article-title: Ionotropic and metabotropic glutamate receptor structure and pharmacology
  publication-title: Psychopharmacology
– volume: 50
  start-page: 639
  year: 2010
  end-page: 643
  ident: bb0740
  article-title: Regional grey matter volume abnormalities in bulimia nervosa and binge-eating disorder
  publication-title: NeuroImage
– volume: 30
  start-page: 662
  year: 2016
  end-page: 675
  ident: bb0345
  article-title: Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model
  publication-title: Journal of Psychopharmacology
– volume: 19
  start-page: 1515
  year: 2011
  end-page: 1518
  ident: bb0300
  article-title: Eating disorder symptomatology in normal-weight vs. obese individuals with binge-eating disorder
  publication-title: Obesity
– volume: 29
  start-page: 1290
  year: 2015
  end-page: 1307
  ident: bb0850
  article-title: Effects of lisdexamfetamine in a rat model of binge-eating
  publication-title: Journal of Psychopharmacology
– volume: 4
  start-page: 1251
  year: 2016
  end-page: 1260
  ident: bb0580
  article-title: Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal Phase 3 randomized controlled trials
  publication-title: Neuropsychopharmacology
– volume: 356
  start-page: 493
  year: 2016
  end-page: 502
  ident: bb2000
  article-title: A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
– volume: 134
  start-page: 807
  year: 2008
  end-page: 828
  ident: bb0220
  article-title: Emotion-based dispositions to rash action: Positive and negative urgency
  publication-title: Psychological Bulletin
– volume: 25
  start-page: 777
  year: 2005
  end-page: 786
  ident: bb0660
  article-title: Hedonic hot spot in nucleus accumbens shell: Where do mu opioids cause increased hedonic impact of sweetness?
  publication-title: The Journal of Neuroscience
– volume: 37
  start-page: 1999
  year: 2012
  end-page: 2011
  ident: bb0675
  article-title: Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats
  publication-title: Neuropsychopharmacology
– volume: 40
  start-page: 1163
  year: 2015
  end-page: 1171
  ident: bb0775
  article-title: The uncompetitive
  publication-title: Neuropsychopharmacology
– volume: 10
  start-page: 1
  year: 2014
  end-page: 12
  ident: bb0875
  article-title: Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: The effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
  publication-title: Neuropsychiatric Disease and Treatment
– volume: 12
  start-page: 3239
  year: 2000
  end-page: 3249
  ident: bb0320
  article-title: Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
  publication-title: The European Journal of Neuroscience
– volume: 41
  start-page: 200
  year: 2001
  end-page: 209
  ident: bb0840
  article-title: Evidence that hypophagia induced by
  publication-title: Neuropharmacology
– volume: 64
  start-page: 1055
  year: 1990
  end-page: 1066
  ident: bb0715
  article-title: Gustatory responses of single neurons in the caudolateral orbitofrontal cortex of the macaque monkey
  publication-title: Journal of Neurophysiology
– volume: 76
  start-page: 852
  year: 2005
  end-page: 857
  ident: bb0820
  article-title: Brain lesions and eating disorders
  publication-title: Neurology, Neurosurgery & Psychiatry
– volume: 12
  start-page: 3549
  year: 2001
  end-page: 3552
  ident: bb0185
  article-title: Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain
  publication-title: Neuroreport
– volume: 98
  start-page: 8966
  year: 2001
  end-page: 8971
  ident: bb0095
  article-title: Trace amines: Identification of a family of mammalian G protein-coupled receptors
  publication-title: Proceedings of the National Academy of Sciences
– start-page: 1
  year: 2016
  end-page: 13
  ident: bb0270
  article-title: The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats
  publication-title: Neuropsychopharmacology
– volume: 44
  start-page: 585
  year: 2011
  end-page: 595
  ident: bb0080
  article-title: Reward abnormalities among women with full and subthreshold bulimia nervosa: A functional magnetic resonance imaging study
  publication-title: The International Journal of Eating Disorders
– volume: 419
  start-page: 163
  year: 2001
  end-page: 174
  ident: bb0545
  article-title: Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice
  publication-title: European Journal of Pharmacology
– volume: 97
  start-page: 89
  year: 2000
  end-page: 97
  ident: bb0795
  article-title: Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
  publication-title: Neuroscience
– volume: 272
  start-page: 93
  year: 2014
  end-page: 99
  ident: bb0005
  article-title: Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement
  publication-title: Behavioural Brain Research
– volume: 111
  start-page: E1648
  year: 2014
  end-page: 1655
  ident: bb0615
  article-title: Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
  publication-title: Proceedings of the National Academy of Sciences
– volume: 154
  start-page: 406
  year: 2008
  end-page: 416
  ident: bb0620
  article-title: Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats
  publication-title: British Journal of Pharmacology
– volume: 16
  start-page: 1042
  year: 2013
  end-page: 1048
  ident: bb0370
  article-title: The fat mass and obesity associated gene (
  publication-title: Nature Neuroscience
– volume: 41
  start-page: 275
  year: 2001
  end-page: 284
  ident: bb0785
  article-title: Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers
  publication-title: Synapse
– volume: 92
  start-page: 528
  year: 2009
  end-page: 536
  ident: bb0925
  article-title: Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions
  publication-title: Pharmacology, Biochemistry, and Behavior
– volume: 81
  start-page: 737
  year: 2016
  end-page: 747
  ident: bb0935
  article-title: Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice
  publication-title: Biological Psychiatry
– volume: 19
  start-page: 975
  year: 2014
  end-page: 985
  ident: bb0725
  article-title: Evidence for a compulsive-like behavior in rats exposed to alternate access to highly preferred palatable food
  publication-title: Addiction Biology
– volume: 40
  start-page: 687
  year: 2007
  end-page: 691
  ident: bb0115
  article-title: Baclofen for binge eating: An open-label trial
  publication-title: The International Journal of Eating Disorders
– volume: 311
  start-page: 861
  year: 2006
  end-page: 863
  ident: bb0165
  article-title: Neurochemical modulation of response inhibition and probabilistic learning in humans
  publication-title: Science
– volume: 10
  start-page: 260
  year: 2004
  end-page: 268
  ident: bb0565
  article-title: The neural substrates of reward processing in humans: The modern role of FMRI
  publication-title: The Neuroscientist
– volume: 61
  start-page: 1070
  year: 2011
  end-page: 1087
  ident: bb0765
  article-title: Endocannabinoid-mediated synaptic plasticity and addiction related behavior
  publication-title: Neuropharmacology
– volume: 19
  start-page: 1601
  year: 2011
  end-page: 1608
  ident: bb0865
  article-title: Enhanced striatal dopamine release during food stimulation in binge eating disorder
  publication-title: Obesity (Silver Spring)
– volume: 60
  start-page: 1181
  year: 2001
  end-page: 1188
  ident: bb0125
  article-title: Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of the rat trace amine receptor
  publication-title: Molecular Pharmacology
– volume: 12
  start-page: 91
  year: 2006
  end-page: 99
  ident: bb0150
  article-title: Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: Preclinical and clinical data
  publication-title: CNS Drug Reviews
– volume: 18
  start-page: 55
  year: 2016
  ident: bb0310
  article-title: Combining pharmacological and psychological treatments for binge eating disorder: Current status, limitations, and future directions
  publication-title: Current Psychiatry Reports
– volume: 120
  start-page: 891
  year: 2012
  end-page: 898
  ident: bb0860
  article-title: Epigenetic dysregulation of the dopamine system in diet induced obesity
  publication-title: Journal of Neurochemistry
– volume: 23
  start-page: 616
  year: 2012
  end-page: 625
  ident: bb0195
  article-title: Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study
  publication-title: Behavioural Pharmacology
– volume: 155
  start-page: 1756
  year: 1998
  end-page: 1762
  ident: bb0380
  article-title: Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial
  publication-title: The American Journal of Psychiatry
– volume: 191
  start-page: 391
  year: 2007
  end-page: 431
  ident: bb0055
  article-title: The debate over dopamine's role in reward: The case for incentive salience
  publication-title: Psychopharmacology
– volume: 169
  start-page: 820
  year: 2013
  end-page: 833
  ident: bb0750
  article-title: Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats
  publication-title: British Journal of Pharmacology
– volume: 65
  start-page: 654
  year: 2009
  end-page: 661
  ident: bb0755
  article-title: Binge-eating disorder: Reward sensitivity and brain activation to images of food
  publication-title: Biological Psychiatry
– volume: 307
  start-page: 25
  year: 2016
  end-page: 34
  ident: bb0330
  article-title: Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating
  publication-title: Behavioural Brain Research
– volume: 13
  start-page: 1444
  year: 2001
  end-page: 1452
  ident: bb0705
  article-title: SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of hypocretin-A in rats
  publication-title: The European Journal of Neuroscience
– volume: 63
  start-page: 1028
  year: 2002
  end-page: 1033
  ident: bb0015
  article-title: A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder
  publication-title: The Journal of Clinical Psychiatry
– volume: 341
  start-page: 39
  year: 1998
  end-page: 44
  ident: bb0285
  article-title: Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
  publication-title: European Journal of Pharmacology
– volume: 27
  start-page: 1081
  year: 2013
  end-page: 1092
  ident: bb0245
  article-title: Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: A head-to-head, randomized, double-blind, phase IIIb study
  publication-title: CNS Drugs
– volume: 48
  start-page: 655
  year: 1992
  end-page: 668
  ident: bb0515
  article-title: Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
  publication-title: Neuroscience
– volume: 106
  start-page: 1
  year: 2001
  end-page: 4
  ident: bb0325
  article-title: Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
  publication-title: Neuroscience
– volume: 18
  start-page: 9996
  year: 1998
  end-page: 10015
  ident: bb0670
  article-title: Neurons containing hypocretin (orexin) project to multiple neuronal systems
  publication-title: The Journal of Neuroscience
– volume: 207
  start-page: 100
  year: 2013
  end-page: 106
  ident: bb0230
  article-title: Influence of negative affect on choice behavior in individuals with binge eating pathology
  publication-title: Psychiatry Research
– volume: 21
  start-page: RC159
  year: 2001
  ident: bb0450
  article-title: Anticipation of increasing monetary reward selectively recruits nucleus accumbens
  publication-title: The Journal of Neuroscience
– volume: 23
  start-page: 1
  year: 2008
  end-page: 11
  ident: bb0315
  article-title: High-dose escitalopram in the treatment of binge-eating disorder with obesity: A placebo-controlled monotherapy trial
  publication-title: Human Psychopharmacology
– volume: 10
  start-page: 2275
  year: 2014
  end-page: 2280
  ident: bb0760
  article-title: Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
  publication-title: Neuropsychiatric Disease and Treatment
– volume: 96
  start-page: 45
  year: 2000
  end-page: 51
  ident: bb0340
  article-title: A selective orexin-1 receptor antagonist reduces food consumption in male and female rats
  publication-title: Regulatory Peptides
– volume: 73
  start-page: 904
  year: 2013
  end-page: 914
  ident: bb0430
  article-title: The prevalence and correlates of binge eating disorder in the World Health Organization world mental health surveys
  publication-title: Biological Psychiatry
– volume: 37
  start-page: 2643
  year: 2012
  end-page: 2652
  ident: bb0290
  article-title: Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating
  publication-title: Neuropsychopharmacology
– volume: 75
  start-page: 825
  year: 2014
  end-page: 832
  ident: bb0010
  article-title: Atomoxetine decreases vulnerability to develop compulsivity in high impulsive rats
  publication-title: Biological Psychiatry
– volume: 44
  start-page: 103
  year: 2005
  end-page: 114
  ident: bb0710
  article-title: At first sight: How do restrained eaters evaluate high-fat palatable foods?
  publication-title: Appetite
– volume: 37
  start-page: 478
  year: 2002
  end-page: 484
  ident: bb0100
  article-title: A potential role for GABA(B) agonists in the treatment of psychostimulant addiction
  publication-title: Alcohol and Alcoholism
– volume: 159
  start-page: 26
  year: 2016
  end-page: 34
  ident: bb0460
  article-title: Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users
  publication-title: Drug and Alcohol Dependence
– volume: 224
  start-page: 501
  year: 2012
  end-page: 509
  ident: bb0160
  article-title: Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals
  publication-title: Psychopharmacology
– volume: 73
  start-page: 887
  year: 2013
  end-page: 894
  ident: bb0135
  article-title: Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people
  publication-title: Biological Psychiatry
– volume: 60
  start-page: 4
  year: 2017
  end-page: 46
  ident: bb0815
  article-title: Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and
  publication-title: Journal of Medicinal Chemistry
– volume: 39
  start-page: 2309
  year: 2014
  end-page: 2316
  ident: bb0790
  article-title: Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats
  publication-title: Neuropsychopharmacology
– volume: 68
  start-page: 390
  year: 2007
  end-page: 398
  ident: bb0575
  article-title: Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial
  publication-title: The Journal of Clinical Psychiatry
– volume: 98
  start-page: 408
  year: 2006
  end-page: 419
  ident: bb0780
  article-title: Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
  publication-title: Journal of Neurochemistry
– volume: 56
  start-page: 507
  year: 2009
  end-page: 513
  ident: bb0475
  article-title: Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens
  publication-title: Neuropharmacology
– volume: 99
  start-page: 29
  year: 2000
  end-page: 42
  ident: bb0415
  article-title: Regional cerebral blood flow during exposure to food in obese binge eating women
  publication-title: Psychiatry Research
– volume: 165
  start-page: 51
  year: 2008
  end-page: 58
  ident: bb0900
  article-title: Efficacy of sibutramine for the treatment of binge eating disorder: A randomized multicenter placebo-controlled double-blind study
  publication-title: The American Journal of Psychiatry
– volume: 204
  start-page: 113
  year: 2009
  end-page: 125
  ident: bb0180
  article-title: A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: Effect of sibutramine, fluoxetine, topiramate and midazolam
  publication-title: Pyschopharmacology
– volume: 64
  start-page: 801
  year: 1995
  end-page: 812
  ident: bb0045
  article-title: Afferent connections of the caudolateral orbitofrontal cortex taste area of the primate
  publication-title: Neuroscience
– volume: 121
  start-page: 877
  year: 2007
  end-page: 886
  ident: bb0260
  article-title: Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and non obese humans
  publication-title: Behavioral Neuroscience
– volume: 168
  start-page: 1210
  year: 2011
  end-page: 1220
  ident: bb0535
  article-title: An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa
  publication-title: American Journal of Psychiatry
– volume: 57
  start-page: 659
  year: 2000
  end-page: 665
  ident: bb0265
  article-title: The natural course of bulimia nervosa and binge eating disorder in young women
  publication-title: Archives of General Psychiatry
– volume: 13
  start-page: 188
  year: 2016
  ident: bb0505
  article-title: Acute stressors reduce neural inhibition to food cues and increase eating among binge eating disorder symptomatic women
  publication-title: Frontiers in Behavioral Neuroscience
– volume: 26
  start-page: 2331
  year: 2005
  end-page: 2338
  ident: bb0895
  article-title: Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity
  publication-title: Peptides
– volume: 125
  start-page: 287
  year: 2015
  end-page: 302
  ident: bb0730
  article-title: Endocannabinoid signaling in motivation, reward, and addiction: Influences on mesocorticolimbic dopamine function
  publication-title: International Review of Neurobiology
– volume: 124
  start-page: 195
  year: 2009
  end-page: 206
  ident: bb0555
  article-title: The pharmacology of sigma-1 receptors
  publication-title: Pharmacology & Therapeutics
– volume: 19
  start-page: 2289
  year: 2009
  end-page: 2294
  ident: bb0880
  article-title: Syntheses of novel high affinity ligands for opioid receptors
  publication-title: Bioorganic & Medicinal Chemistry Letters
– volume: 20
  start-page: 631
  year: 2009
  end-page: 634
  ident: bb0050
  article-title: Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet
  publication-title: Behavioural Pharmacology
– volume: 22
  start-page: 3306
  year: 2002
  end-page: 3311
  ident: bb0420
  article-title: The neuroscience of natural rewards: Relevance to addictive drugs
  publication-title: The Journal of Neuroscience
– volume: 46
  start-page: 239
  year: 2013
  end-page: 245
  ident: bb0570
  article-title: A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder
  publication-title: The International Journal of Eating Disorders
– volume: 23
  start-page: 1486
  year: 2004
  end-page: 1493
  ident: bb0665
  article-title: Images of desire: Food-craving activation during fMRI
  publication-title: NeuroImage
– volume: 140
  start-page: 790
  year: 2003
  end-page: 801
  ident: bb0720
  article-title: Anandamide and vanilloid TRPV1 receptors
  publication-title: British Journal of Pharmacology
– volume: 42
  start-page: 1511
  year: 2016
  end-page: 1521
  ident: bb0835
  article-title: Activation of ventral tegmental area 5-HT2C receptors reduces incentive motivation
  publication-title: Neuropsychopharmacology
– volume: 15
  start-page: 115
  year: 2014
  end-page: 123
  ident: bb0145
  article-title: Gamma aminobutyric acidergic and neuronal structural markers in the nucleus accumbens core underlie trait-like impulsive behavior
  publication-title: Biological Psychiatry
– volume: 32
  start-page: 1599
  year: 2008
  end-page: 1605
  ident: bb0480
  article-title: A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorder
  publication-title: Progress in Neuro-Psychopharmacology & Biological Psychiatry
– volume: 5
  start-page: 256
  year: 1997
  end-page: 262
  ident: bb0510
  article-title: Impulsive and self-control choices in opioid-dependent patients and non-drug using control participants: Drug and monetary rewards
  publication-title: Experimental and Clinical Psychopharmacology
– volume: 62
  start-page: 642
  year: 2007
  end-page: 651
  ident: bb0110
  article-title: Neural substrates of resisting craving during cigarette cue exposure
  publication-title: Biological Psychiatry
– volume: 33
  start-page: 1028
  year: 2008
  end-page: 1037
  ident: bb0700
  article-title: Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat
  publication-title: Neuropsychopharmacology
– volume: 14
  start-page: 137
  year: 1990
  end-page: 141
  ident: bb0885
  article-title: Some restrictions on dietary restraint
  publication-title: Appetite
– volume: 134
  start-page: 693
  year: 2015
  end-page: 703
  ident: bb0385
  article-title: Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus
  publication-title: Journal of Neurochemistry
– volume: 31
  start-page: 3249
  year: 2011
  end-page: 3260
  ident: bb0600
  article-title: Induction of hyperphagia and carbohydrate intake by μ-opioid receptor stimulation in circumscribed region of frontal cortex
  publication-title: The Journal of Neuroscience
– volume: 435
  start-page: 6
  year: 2001
  end-page: 25
  ident: bb0530
  article-title: Differential expression of orexin receptors 1 and 2 in the rat brain
  publication-title: Journal of Comparative Neurology
– volume: 30
  start-page: 619
  year: 2001
  end-page: 639
  ident: bb0105
  article-title: Functional imaging of neural responses to expectancy and experience of monetary gains and losses
  publication-title: Neuron
– volume: 41
  start-page: 520
  year: 2008
  end-page: 526
  ident: bb3000
  article-title: Memantine in the Treatment of Binge Eating Disorder: An Open-Label, Prospective Trial
  publication-title: The International Journal of Eating Disorders
– volume: 72
  start-page: 341
  year: 2004
  end-page: 372
  ident: bb0465
  article-title: The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology
  publication-title: Progress in Neurobiology
– volume: 39
  start-page: 2309
  year: 2014
  end-page: 2316
  ident: bb0805
  article-title: Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats
  publication-title: Neuropsychopharmacology
– volume: 19
  start-page: 849
  year: 2014
  end-page: 861
  ident: bb0250
  article-title: The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food
  publication-title: Addiction Biology
– volume: 210
  start-page: 243
  year: 2012
  end-page: 248
  ident: bb0175
  article-title: Orexin signaling in the paraventricular thalamic nucleus modulates mesolimbic dopamine and hedonic feeding in the rat
  publication-title: Neuroscience
– volume: 46
  start-page: 31
  year: 2006
  end-page: 35
  ident: bb0280
  article-title: Responsivity to food stimuli in obese and lean binge eaters using functional MRI
  publication-title: Appetite
– volume: 289
  start-page: 19
  year: 2015
  end-page: 42
  ident: bb0495
  article-title: Regulation of the mesolimbic dopamine circuit by feeding peptides
  publication-title: Neuroscience
– volume: 18
  start-page: 263
  year: 2003
  end-page: 272
  ident: bb0455
  article-title: A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: Characterization with rapid event-related fMRI
  publication-title: NeuroImage
– volume: 141B
  start-page: 7
  year: 2006
  end-page: 9
  ident: bb0605
  article-title: Association of a functional serotonin transporter gene polymorphism with binge eating disorder
  publication-title: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
– volume: 90
  start-page: 928
  year: 2009
  end-page: 934
  ident: bb0560
  article-title: Differential functional magnetic resonance imaging response to food pictures in successful weight-loss maintainers relative to normal-weight and obese controls
  publication-title: The American Journal of Clinical Nutrition
– volume: 25
  start-page: 340
  year: 2001
  end-page: 345
  ident: bb0920
  article-title: Psychological and behavioral predictors of weight loss during drug treatment for obesity
  publication-title: International Journal of Obesity and Related Metabolic Disorders
– volume: 65
  start-page: 209
  year: 2002
  end-page: 220
  ident: bb0210
  article-title: GABAB receptor agonists for the treatment of drug addiction: A review of recent findings
  publication-title: Drug and Alcohol Dependence
– volume: 233
  start-page: 2841
  year: 2016
  end-page: 2856
  ident: bb0375
  article-title: Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists
  publication-title: Psychopharmacology
– volume: 155
  start-page: 310
  year: 2001
  end-page: 314
  ident: bb0470
  article-title: Reduced serotonin transporter binding in binge eating women
  publication-title: Psychopharmacology
– volume: 22
  start-page: 1027
  year: 2012
  end-page: 1038
  ident: bb0485
  article-title: The root of all value: A neural common currency for choice
  publication-title: Current Opinion in Neurobiology
– volume: 15
  start-page: 1857
  year: 2004
  end-page: 1860
  ident: bb0910
  article-title: The amygdala is critical for opioid-mediated binge eating of fat
  publication-title: Neuroreport
– volume: 31
  start-page: 770
  year: 2017
  end-page: 783
  ident: bb0350
  article-title: Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats — Possible relevance in the psychopathology and treatment of binge-eating disorder
  publication-title: Journal of Psychopharmacology
– volume: 77
  start-page: 434
  year: 2015
  end-page: 444
  ident: bb0040
  article-title: Anticipatory reward processing in addicted populations: A focus on the monetary incentive delay task
  publication-title: Biological Psychiatry
– volume: 86
  start-page: 766
  year: 2007
  end-page: 773
  ident: bb0275
  article-title: Effects of the cannabinoid antagonist SR141716 (rimonabant) and
  publication-title: Pharmacology Biochemistry and Behavior
– volume: 64
  start-page: 807
  year: 2003
  end-page: 813
  ident: bb0585
  article-title: Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial
  publication-title: The Journal of Clinical Psychiatry
– volume: 17
  start-page: 1220
  year: 2009
  end-page: 1225
  ident: bb0235
  article-title: Dopamine for wanting and opioids for liking: A comparison of obese adults with and without binge eating
  publication-title: Obesity
– volume: 87
  start-page: 1
  year: 2014
  end-page: 3
  ident: bb0355
  article-title: CNS stimulants
  publication-title: Neuropharmacology
– volume: 18
  start-page: 1710
  year: 2010
  end-page: 1717
  ident: bb0225
  article-title: A model of binge-like eating behavior in mice that does not require food deprivation or stress
  publication-title: Obesity
– volume: 205
  start-page: 489
  year: 2009
  end-page: 502
  ident: bb0650
  article-title: Acute effects of morphine on distinct forms of impulsive behavior in rats
  publication-title: Psychopharmacology
– volume: 2
  start-page: 367
  year: 2013
  end-page: 377
  ident: bb0035
  article-title: Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity
  publication-title: Obesity (Silver Spring)
– volume: 63
  start-page: 234
  year: 2008
  end-page: 240
  ident: bb0690
  article-title: Deactivation of the limbic system during acute psychosocial stress: Evidence from positron emission tomography and functional magnetic resonance imaging studies
  publication-title: Biological Psychiatry
– volume: 60
  start-page: 206
  year: 2015
  end-page: 216
  ident: bb0830
  article-title: Escalation in high fat intake in a binge eating model differentially engages dopamine neurons of the ventral tegmental area and requires ghrelin signaling
  publication-title: Psychoneuroendocrinology
– volume: 20
  start-page: 566
  year: 2015
  end-page: 573
  ident: bb0855
  article-title: Cognitive biases in binge eating disorder: The hijacking of decision making
  publication-title: CNS Spectrums
– volume: 368
  start-page: 20120380
  year: 2013
  ident: bb0065
  article-title: Genetics of impulsive behavior
  publication-title: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
– volume: 368
  start-page: 1660
  year: 2006
  end-page: 1672
  ident: bb0745
  article-title: Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study
  publication-title: Lancet
– volume: 18
  start-page: 1287
  year: 2013
  end-page: 1293
  ident: bb0940
  article-title: Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: A proof of mechanism study in binge-eating obese subjects
  publication-title: Molecular Psychiatry
– volume: 14
  start-page: 583
  year: 2003
  end-page: 588
  ident: bb0595
  article-title: The cannabinoid CB1 antagonists SR141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
  publication-title: Behavioural Pharmacology
– volume: 40
  start-page: 477
  year: 2011
  end-page: 485
  ident: bb0680
  article-title: Memantine reduces consumption of highly palatable food in a rat model of binge eating
  publication-title: Amino Acids
– volume: 75
  start-page: 487
  year: 2014
  end-page: 498
  ident: bb0365
  article-title: Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates
  publication-title: Biological Psychiatry
– volume: 34
  start-page: 172
  year: 2010
  end-page: 181
  ident: bb0090
  article-title: Acute stress and food-related reward activation in the brain during food choice during eating in the absence of hunger
  publication-title: International Journal of Obesity
– volume: 73
  start-page: 877
  year: 2013
  end-page: 886
  ident: bb0030
  article-title: Monetary reward processing in obese individuals with and without binge eating disorder
  publication-title: Biological Psychiatry
– volume: 87
  start-page: 41
  year: 2014
  end-page: 50
  ident: bb0390
  article-title: Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: A novel
  publication-title: Neuropharmacology
– volume: 77
  start-page: 299
  year: 1997
  end-page: 318
  ident: bb0295
  article-title: Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
  publication-title: Neuroscience
– volume: 14
  start-page: 383
  year: 2013
  end-page: 400
  ident: bb0635
  article-title: NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease
  publication-title: Nature Reviews. Neuroscience
– volume: 170
  start-page: 89
  year: 2003
  end-page: 93
  ident: bb0800
  article-title: Treatment improves serotonin transporter binding and reduces binge eating
  publication-title: Psychopharmacology
– volume: 55
  start-page: 1067
  year: 1990
  end-page: 1070
  ident: bb0155
  article-title: Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals
  publication-title: Journal of Neurochemistry
– volume: 107
  start-page: 1
  year: 2012
  end-page: 21
  ident: bb0640
  article-title: Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: Lack of withdrawal-like responses
  publication-title: Physiology & Behavior
– volume: 66
  start-page: 33
  year: 2016
  end-page: 53
  ident: bb0255
  article-title: Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
  publication-title: Neuroscience and Biobehavioral Reviews
– volume: 324
  start-page: 948
  year: 2008
  end-page: 956
  ident: bb0490
  article-title: Trace amine-associated receptor 1 modulates dopaminergic activity
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
– volume: 365
  start-page: 61
  year: 1993
  end-page: 65
  ident: bb0610
  article-title: Molecular characterization of a peripheral receptor for cannabinoids
  publication-title: Nature
– volume: 63
  start-page: 223
  year: 2016
  end-page: 238
  ident: bb0435
  article-title: The neurobiological basis of binge-eating disorder
  publication-title: Neuroscience and Biobehavioral Reviews
– volume: 18
  start-page: 794
  year: 2008
  end-page: 802
  ident: bb0070
  article-title: Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder
  publication-title: European Neuropsychopharmacology
– volume: 253
  start-page: 858
  year: 1990
  end-page: 866
  ident: bb0410
  article-title: Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
– volume: 1350
  start-page: 43
  year: 2010
  end-page: 64
  ident: bb0060
  article-title: The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
  publication-title: Brain Research
– volume: 105
  start-page: 734
  year: 2012
  end-page: 741
  ident: bb0695
  article-title: Rimonabant reduces the essential value of food in the genetically obese Zucker rat: An exponential demand analysis
  publication-title: Physiology and Behavior
– volume: 6
  start-page: 147
  year: 2003
  end-page: 151
  ident: bb0655
  article-title: A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: A high placebo response
  publication-title: Archives of Women's Mental Health
– volume: 23
  start-page: 2882
  year: 2003
  end-page: 2888
  ident: bb0905
  article-title: Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network
  publication-title: The Journal of Neuroscience
– volume: 132
  start-page: 1
  year: 2016
  end-page: 4
  ident: bb0140
  article-title: Delay discounting predicts binge-eating in Wistar rats
  publication-title: Behavioural Processes
– volume: 20
  start-page: 557
  year: 2015
  end-page: 565
  ident: bb0025
  article-title: Neurobiological features of binge eating disorder
  publication-title: CNS Spectrums
– volume: 33
  start-page: 2135
  year: 2012
  end-page: 2146
  ident: bb0890
  article-title: Diagnosing different binge-eating disorders based on reward-related brain activation patterns
  publication-title: Human Brain Mapping
– volume: 339
  start-page: 24
  year: 2011
  end-page: 34
  ident: bb0405
  article-title: Regulation of ingestive behaviors in the rat by GSK1521498, a novel μ-opioid receptor-selective inverse agonist
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
– volume: 1
  start-page: 51
  year: 2009
  end-page: 63
  ident: bb0540
  article-title: Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa
  publication-title: Archives of General Psychiatry
– volume: 19
  start-page: 652
  year: 2014
  end-page: 662
  ident: bb0075
  article-title: Opioid system in the medial prefrontal cortex mediates binge-like eating
  publication-title: Addiction Biology
– volume: 42
  start-page: 1169
  year: 2016
  end-page: 1177
  ident: bb0520
  article-title: Dopamine and opioid neurotransmission in behavioral addictions: A comparative PET study in pathological gambling and binge eating
  publication-title: Neuropsychopharmacology
– volume: 110
  start-page: 86
  year: 1991
  end-page: 108
  ident: bb0360
  article-title: Binge eating as escape from self-awareness
  publication-title: Psychological Bulletin
– volume: 32
  start-page: 451
  year: 2011
  end-page: 462
  ident: bb0735
  article-title: Connectomics of orexin-producing neurons: Interface of systems of emotion, energy homeostasis and arousal
  publication-title: Trends in Pharmacological Sciences
– volume: 29
  start-page: 565
  year: 2006
  end-page: 598
  ident: bb0400
  article-title: Neural mechanisms of addiction: The role of reward-related learning and memory
  publication-title: Annual Review of Neuroscience (Palo Alto, CA)
– volume: 37
  start-page: 2593
  year: 2012
  end-page: 2604
  ident: bb0205
  article-title: Antagonism of sigma-1 receptors blocks compulsive-like eating
  publication-title: Neuropsychopharmacology
– volume: 150
  start-page: 2668
  year: 2009
  end-page: 2673
  ident: bb0550
  article-title: Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice
  publication-title: Endocrinology
– volume: 31
  start-page: 784
  year: 2017
  end-page: 797
  ident: bb0845
  article-title: Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the
  publication-title: Journal of Psychopharmacology
– volume: 314
  start-page: 770
  year: 2005
  end-page: 779
  ident: bb0500
  article-title: Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
– volume: 42
  start-page: 139
  year: 2004
  end-page: 142
  ident: bb0190
  article-title: Binge-type eating induced by limited access in rats does not require energy restriction on the previous day
  publication-title: Appetite
– volume: 11
  start-page: 1393
  year: 2016
  end-page: 1401
  ident: bb0770
  article-title: Neural signature of food reward processing in bulimic-type eating disorders
  publication-title: Social Cognitive and Affective Neuroscience
– volume: 143
  start-page: 253
  year: 2014
  end-page: 264
  ident: bb0395
  article-title: Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders
  publication-title: Pharmacology & Therapeutics
– volume: 226
  start-page: 189
  year: 2013
  end-page: 200
  ident: bb0825
  article-title: A review of the abuse potential assessment of atomoxetine: A nonstimulant medication for attention-deficit/hyperactivity disorder
  publication-title: Psychopharmacology
– volume: 49
  start-page: 930
  year: 2016
  end-page: 936
  ident: bb0130
  article-title: Effects of transcranial direct current stimulation (tDCS) on binge eating disorder
  publication-title: The International Journal of Eating Disorders
– volume: 12
  start-page: 13
  year: 2012
  end-page: 26
  ident: bb0170
  article-title: The use of lisdexamfetamine dimesylate for the treatment of ADHD
  publication-title: Expert Review of Neurotherapeutics
– volume: 69
  start-page: 1424
  year: 2007
  end-page: 1433
  ident: bb0930
  article-title: Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia
  publication-title: Neurology
– volume: 47
  start-page: 376
  year: 2014
  end-page: 384
  ident: bb0020
  article-title: A pilot study linking reduced fronto-striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder
  publication-title: The International Journal of Eating Disorders
– volume: 86
  start-page: 176
  year: 2005
  end-page: 184
  ident: bb0120
  article-title: Baclofen reduces fat intake under binge-type conditions
  publication-title: Physiology & Behavior
– volume: 438
  start-page: 71
  year: 1998
  end-page: 75
  ident: bb0810
  article-title: Distribution of orexin receptor mRNA in the rat brain
  publication-title: FEBS Letters
– volume: 38
  start-page: 1081
  year: 1986
  end-page: 1088
  ident: bb0305
  article-title: The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors
  publication-title: Life Sciences
– volume: 24
  start-page: 223
  year: 2016
  end-page: 231
  ident: bb0590
  article-title: Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder
  publication-title: European Eating Disorders Review
– volume: 25
  start-page: 705
  year: 2014
  end-page: 716
  ident: bb0085
  article-title: Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets
  publication-title: Behavioural Pharmacology
– volume: 7
  start-page: 153
  year: 2004
  end-page: 159
  ident: bb0215
  article-title: Bidirectional effects of GABA(B) receptor agonists on the mesolimbic dopamine system
  publication-title: Nature Neuroscience
– volume: 121
  start-page: 20
  year: 2013
  end-page: 26
  ident: bb0645
  article-title: Efficacy of rimonabant in obese patients with binge eating disorder
  publication-title: Experimental and Clinical Endocrinology & Diabetes
– volume: 375
  start-page: 1717
  year: 2016
  end-page: 1725
  ident: bb0425
  article-title: Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase
  publication-title: The New England Journal of Medicine
– volume: 61
  start-page: 561
  year: 2011
  end-page: 582
  ident: bb0525
  article-title: Discounting of various types of rewards by women with and without binge eating disorder: Evidence for general rather than specific differences
  publication-title: Psychological Record
– volume: 3
  start-page: 1273
  year: 2006
  end-page: 1280
  ident: bb0685
  article-title: Subjective feeling of appetite modulates brain activity: An fMRI study
  publication-title: NeuroImage
– volume: 26
  start-page: 299
  year: 2002
  end-page: 307
  ident: bb0240
  article-title: Binge eating disorder: A review
  publication-title: International Journal of Obesity
– volume: 141
  start-page: 283
  year: 2014
  end-page: 299
  ident: bb0915
  article-title: The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence
  publication-title: Pharmacology & Therapeutics
– year: 2016, Nov 9
  ident: bb0445
  article-title: Stress-induced eating in women with binge-eating disorder and obesity
  publication-title: Biological Psychology
– volume: 215
  start-page: 611
  year: 2010
  end-page: 616
  ident: bb0625
  article-title: Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
  publication-title: Immunobiology
– volume: 9
  start-page: 299
  year: 2017
  ident: bb0630
  article-title: The efficacy of psychological therapies in reducing weight and binge eating in people with bulimia nervosa and binge eating disorder who are overweight or obese—A critical synthesis and meta-analyses
  publication-title: Nutrients
– volume: 64
  start-page: 1055
  year: 1990
  ident: 10.1016/j.pharmthera.2017.08.002_bb0715
  article-title: Gustatory responses of single neurons in the caudolateral orbitofrontal cortex of the macaque monkey
  publication-title: Journal of Neurophysiology
  doi: 10.1152/jn.1990.64.4.1055
– volume: 20
  start-page: 631
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0050
  article-title: Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet
  publication-title: Behavioural Pharmacology
  doi: 10.1097/FBP.0b013e328331ba47
– volume: 40
  start-page: 477
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0680
  article-title: Memantine reduces consumption of highly palatable food in a rat model of binge eating
  publication-title: Amino Acids
  doi: 10.1007/s00726-010-0659-3
– volume: 23
  start-page: 1
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0315
  article-title: High-dose escitalopram in the treatment of binge-eating disorder with obesity: A placebo-controlled monotherapy trial
  publication-title: Human Psychopharmacology
  doi: 10.1002/hup.899
– volume: 15
  start-page: 1857
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0910
  article-title: The amygdala is critical for opioid-mediated binge eating of fat
  publication-title: Neuroreport
  doi: 10.1097/00001756-200408260-00004
– volume: 56
  start-page: 507
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0475
  article-title: Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2008.10.005
– volume: 77
  start-page: 299
  year: 1997
  ident: 10.1016/j.pharmthera.2017.08.002_bb0295
  article-title: Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(96)00428-9
– volume: 39
  start-page: 1921
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0335
  article-title: Brain γ-aminobutyric acid: A neglected role in impulsivity
  publication-title: The European Journal of Neuroscience
  doi: 10.1111/ejn.12485
– volume: 125
  start-page: 287
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0730
  article-title: Endocannabinoid signaling in motivation, reward, and addiction: Influences on mesocorticolimbic dopamine function
  publication-title: International Review of Neurobiology
– volume: 75
  start-page: 825
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0010
  article-title: Atomoxetine decreases vulnerability to develop compulsivity in high impulsive rats
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2013.09.031
– volume: 1350
  start-page: 43
  year: 2010
  ident: 10.1016/j.pharmthera.2017.08.002_bb0060
  article-title: The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
  publication-title: Brain Research
  doi: 10.1016/j.brainres.2010.04.003
– volume: 4
  start-page: 1251
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0580
  article-title: Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal Phase 3 randomized controlled trials
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.275
– volume: 76
  start-page: 852
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0820
  article-title: Brain lesions and eating disorders
  publication-title: Neurology, Neurosurgery & Psychiatry
  doi: 10.1136/jnnp.2004.048819
– volume: 41
  start-page: 520
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb3000
  article-title: Memantine in the Treatment of Binge Eating Disorder: An Open-Label, Prospective Trial
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.20541
– volume: 13
  start-page: 1444
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0705
  article-title: SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of hypocretin-A in rats
  publication-title: The European Journal of Neuroscience
  doi: 10.1046/j.0953-816x.2001.01518.x
– volume: 98
  start-page: 408
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0780
  article-title: Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats
  publication-title: Journal of Neurochemistry
  doi: 10.1111/j.1471-4159.2006.03880.x
– volume: 46
  start-page: 31
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0280
  article-title: Responsivity to food stimuli in obese and lean binge eaters using functional MRI
  publication-title: Appetite
  doi: 10.1016/j.appet.2005.09.002
– volume: 37
  start-page: 2593
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0205
  article-title: Antagonism of sigma-1 receptors blocks compulsive-like eating
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2012.89
– volume: 134
  start-page: 693
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0385
  article-title: Effects of lisdexamfetamine alone and in combination with s-citalopram on acetylcholine and histamine efflux in the rat pre-frontal cortex and ventral hippocampus
  publication-title: Journal of Neurochemistry
  doi: 10.1111/jnc.13157
– volume: 124
  start-page: 195
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0555
  article-title: The pharmacology of sigma-1 receptors
  publication-title: Pharmacology & Therapeutics
  doi: 10.1016/j.pharmthera.2009.07.001
– volume: 81
  start-page: 737
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0935
  article-title: Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2016.06.005
– volume: 96
  start-page: 45
  year: 2000
  ident: 10.1016/j.pharmthera.2017.08.002_bb0340
  article-title: A selective orexin-1 receptor antagonist reduces food consumption in male and female rats
  publication-title: Regulatory Peptides
  doi: 10.1016/S0167-0115(00)00199-3
– volume: 47
  start-page: 376
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0020
  article-title: A pilot study linking reduced fronto-striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.22204
– volume: 106
  start-page: 1
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0325
  article-title: Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(01)00287-1
– volume: 356
  start-page: 493
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb2000
  article-title: A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1124/jpet.115.228221
– volume: 55
  start-page: 1067
  year: 1990
  ident: 10.1016/j.pharmthera.2017.08.002_bb0155
  article-title: Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals
  publication-title: Journal of Neurochemistry
  doi: 10.1111/j.1471-4159.1990.tb04599.x
– volume: 31
  start-page: 770
  year: 2017
  ident: 10.1016/j.pharmthera.2017.08.002_bb0350
  article-title: Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats — Possible relevance in the psychopathology and treatment of binge-eating disorder
  publication-title: Journal of Psychopharmacology
  doi: 10.1177/0269881117699607
– volume: 314
  start-page: 770
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0500
  article-title: Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1124/jpet.105.084525
– volume: 307
  start-page: 25
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0330
  article-title: Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating
  publication-title: Behavioural Brain Research
  doi: 10.1016/j.bbr.2016.03.046
– volume: 87
  start-page: 41
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0390
  article-title: Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: A novel d-amphetamine pro-drug
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2014.02.014
– volume: 165
  start-page: 51
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0900
  article-title: Efficacy of sibutramine for the treatment of binge eating disorder: A randomized multicenter placebo-controlled double-blind study
  publication-title: The American Journal of Psychiatry
  doi: 10.1176/appi.ajp.2007.06121970
– volume: 210
  start-page: 243
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0175
  article-title: Orexin signaling in the paraventricular thalamic nucleus modulates mesolimbic dopamine and hedonic feeding in the rat
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2012.02.036
– volume: 42
  start-page: 139
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0190
  article-title: Binge-type eating induced by limited access in rats does not require energy restriction on the previous day
  publication-title: Appetite
  doi: 10.1016/j.appet.2003.08.010
– volume: 98
  start-page: 8966
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0095
  article-title: Trace amines: Identification of a family of mammalian G protein-coupled receptors
  publication-title: Proceedings of the National Academy of Sciences
  doi: 10.1073/pnas.151105198
– volume: 15
  start-page: 115
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0145
  article-title: Gamma aminobutyric acidergic and neuronal structural markers in the nucleus accumbens core underlie trait-like impulsive behavior
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2013.07.013
– volume: 46
  start-page: 239
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0570
  article-title: A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.22114
– volume: 38
  start-page: 1081
  year: 1986
  ident: 10.1016/j.pharmthera.2017.08.002_bb0305
  article-title: The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors
  publication-title: Life Sciences
  doi: 10.1016/0024-3205(86)90243-2
– volume: 62
  start-page: 642
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0110
  article-title: Neural substrates of resisting craving during cigarette cue exposure
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.10.026
– volume: 69
  start-page: 1424
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0930
  article-title: Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000277461.06713.23
– volume: 33
  start-page: 524
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0200
  article-title: Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301430
– volume: 37
  start-page: 478
  year: 2002
  ident: 10.1016/j.pharmthera.2017.08.002_bb0100
  article-title: A potential role for GABA(B) agonists in the treatment of psychostimulant addiction
  publication-title: Alcohol and Alcoholism
  doi: 10.1093/alcalc/37.5.478
– volume: 18
  start-page: 263
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0455
  article-title: A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: Characterization with rapid event-related fMRI
  publication-title: NeuroImage
  doi: 10.1016/S1053-8119(02)00057-5
– volume: 61
  start-page: 561
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0525
  article-title: Discounting of various types of rewards by women with and without binge eating disorder: Evidence for general rather than specific differences
  publication-title: Psychological Record
  doi: 10.1007/BF03395777
– volume: 31
  start-page: 784
  year: 2017
  ident: 10.1016/j.pharmthera.2017.08.002_bb0845
  article-title: Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine: Lisdexamfetamine on impulsivity in binge-eating
  publication-title: Journal of Psychopharmacology
  doi: 10.1177/0269881117691672
– volume: 7
  start-page: 153
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0215
  article-title: Bidirectional effects of GABA(B) receptor agonists on the mesolimbic dopamine system
  publication-title: Nature Neuroscience
  doi: 10.1038/nn1181
– volume: 39
  start-page: 2309
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0805
  article-title: Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.91
– volume: 105
  start-page: 734
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0695
  article-title: Rimonabant reduces the essential value of food in the genetically obese Zucker rat: An exponential demand analysis
  publication-title: Physiology and Behavior
  doi: 10.1016/j.physbeh.2011.10.009
– volume: 48
  start-page: 655
  year: 1992
  ident: 10.1016/j.pharmthera.2017.08.002_bb0515
  article-title: Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
  publication-title: Neuroscience
  doi: 10.1016/0306-4522(92)90409-U
– volume: 215
  start-page: 611
  year: 2010
  ident: 10.1016/j.pharmthera.2017.08.002_bb0625
  article-title: Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2009.09.007
– volume: 168
  start-page: 1210
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0535
  article-title: An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa
  publication-title: American Journal of Psychiatry
  doi: 10.1176/appi.ajp.2011.11010094
– volume: 63
  start-page: 234
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0690
  article-title: Deactivation of the limbic system during acute psychosocial stress: Evidence from positron emission tomography and functional magnetic resonance imaging studies
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2007.04.041
– volume: 121
  start-page: 877
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0260
  article-title: Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and non obese humans
  publication-title: Behavioral Neuroscience
  doi: 10.1037/0735-7044.121.5.877
– volume: 86
  start-page: 766
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0275
  article-title: Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in nonhuman primates
  publication-title: Pharmacology Biochemistry and Behavior
  doi: 10.1016/j.pbb.2007.03.004
– volume: 29
  start-page: 1290
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0850
  article-title: Effects of lisdexamfetamine in a rat model of binge-eating
  publication-title: Journal of Psychopharmacology
  doi: 10.1177/0269881115615107
– volume: 12
  start-page: 3549
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0185
  article-title: Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain
  publication-title: Neuroreport
  doi: 10.1097/00001756-200111160-00035
– volume: 18
  start-page: 55
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0310
  article-title: Combining pharmacological and psychological treatments for binge eating disorder: Current status, limitations, and future directions
  publication-title: Current Psychiatry Reports
  doi: 10.1007/s11920-016-0696-z
– volume: 22
  start-page: 1027
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0485
  article-title: The root of all value: A neural common currency for choice
  publication-title: Current Opinion in Neurobiology
  doi: 10.1016/j.conb.2012.06.001
– volume: 63
  start-page: 1028
  year: 2002
  ident: 10.1016/j.pharmthera.2017.08.002_bb0015
  article-title: A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder
  publication-title: The Journal of Clinical Psychiatry
  doi: 10.4088/JCP.v63n1113
– volume: 233
  start-page: 2841
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0375
  article-title: Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-016-4329-3
– volume: 14
  start-page: 137
  year: 1990
  ident: 10.1016/j.pharmthera.2017.08.002_bb0885
  article-title: Some restrictions on dietary restraint
  publication-title: Appetite
  doi: 10.1016/0195-6663(90)90014-Y
– volume: 37
  start-page: 1999
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0675
  article-title: Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2012.48
– volume: 64
  start-page: 807
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0585
  article-title: Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial
  publication-title: The Journal of Clinical Psychiatry
  doi: 10.4088/JCP.v64n0711
– volume: 289
  start-page: 19
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0495
  article-title: Regulation of the mesolimbic dopamine circuit by feeding peptides
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2014.12.046
– volume: 66
  start-page: 33
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0255
  article-title: Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
  publication-title: Neuroscience and Biobehavioral Reviews
  doi: 10.1016/j.neubiorev.2016.03.032
– volume: 99
  start-page: 29
  year: 2000
  ident: 10.1016/j.pharmthera.2017.08.002_bb0415
  article-title: Regional cerebral blood flow during exposure to food in obese binge eating women
  publication-title: Psychiatry Research
  doi: 10.1016/S0925-4927(00)00053-6
– volume: 170
  start-page: 89
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0800
  article-title: Treatment improves serotonin transporter binding and reduces binge eating
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-003-1519-6
– volume: 25
  start-page: 340
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0920
  article-title: Psychological and behavioral predictors of weight loss during drug treatment for obesity
  publication-title: International Journal of Obesity and Related Metabolic Disorders
  doi: 10.1038/sj.ijo.0801551
– volume: 18
  start-page: 1287
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0940
  article-title: Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: A proof of mechanism study in binge-eating obese subjects
  publication-title: Molecular Psychiatry
  doi: 10.1038/mp.2012.154
– volume: 272
  start-page: 93
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0005
  article-title: Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement
  publication-title: Behavioural Brain Research
  doi: 10.1016/j.bbr.2014.06.049
– volume: 5
  start-page: 256
  year: 1997
  ident: 10.1016/j.pharmthera.2017.08.002_bb0510
  article-title: Impulsive and self-control choices in opioid-dependent patients and non-drug using control participants: Drug and monetary rewards
  publication-title: Experimental and Clinical Psychopharmacology
  doi: 10.1037/1064-1297.5.3.256
– volume: 41
  start-page: 275
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0785
  article-title: Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers
  publication-title: Synapse
  doi: 10.1002/syn.1084
– volume: 339
  start-page: 24
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0405
  article-title: Regulation of ingestive behaviors in the rat by GSK1521498, a novel μ-opioid receptor-selective inverse agonist
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1124/jpet.111.180943
– volume: 49
  start-page: 930
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0130
  article-title: Effects of transcranial direct current stimulation (tDCS) on binge eating disorder
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.22554
– volume: 19
  start-page: 1515
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0300
  article-title: Eating disorder symptomatology in normal-weight vs. obese individuals with binge-eating disorder
  publication-title: Obesity
  doi: 10.1038/oby.2011.24
– volume: 435
  start-page: 6
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0530
  article-title: Differential expression of orexin receptors 1 and 2 in the rat brain
  publication-title: Journal of Comparative Neurology
  doi: 10.1002/cne.1190
– volume: 155
  start-page: 1756
  year: 1998
  ident: 10.1016/j.pharmthera.2017.08.002_bb0380
  article-title: Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial
  publication-title: The American Journal of Psychiatry
  doi: 10.1176/ajp.155.12.1756
– volume: 22
  start-page: 3306
  year: 2002
  ident: 10.1016/j.pharmthera.2017.08.002_bb0420
  article-title: The neuroscience of natural rewards: Relevance to addictive drugs
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.22-09-03306.2002
– volume: 375
  start-page: 1717
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0425
  article-title: Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase
  publication-title: The New England Journal of Medicine
  doi: 10.1056/NEJMoa1604221
– volume: 10
  start-page: 1
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0875
  article-title: Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: The effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
  publication-title: Neuropsychiatric Disease and Treatment
– volume: 27
  start-page: 1081
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0245
  article-title: Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: A head-to-head, randomized, double-blind, phase IIIb study
  publication-title: CNS Drugs
  doi: 10.1007/s40263-013-0104-8
– volume: 150
  start-page: 2668
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0550
  article-title: Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice
  publication-title: Endocrinology
  doi: 10.1210/en.2008-1515
– volume: 73
  start-page: 904
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0430
  article-title: The prevalence and correlates of binge eating disorder in the World Health Organization world mental health surveys
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2012.11.020
– volume: 97
  start-page: 89
  year: 2000
  ident: 10.1016/j.pharmthera.2017.08.002_bb0795
  article-title: Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(00)00036-1
– volume: 73
  start-page: 887
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0135
  article-title: Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2012.10.022
– volume: 132
  start-page: 1
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0140
  article-title: Delay discounting predicts binge-eating in Wistar rats
  publication-title: Behavioural Processes
  doi: 10.1016/j.beproc.2016.08.011
– start-page: 1
  issue: 2016
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0270
  article-title: The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats
  publication-title: Neuropsychopharmacology
– volume: 438
  start-page: 71
  year: 1998
  ident: 10.1016/j.pharmthera.2017.08.002_bb0810
  article-title: Distribution of orexin receptor mRNA in the rat brain
  publication-title: FEBS Letters
  doi: 10.1016/S0014-5793(98)01266-6
– volume: 6
  start-page: 147
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0655
  article-title: A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: A high placebo response
  publication-title: Archives of Women's Mental Health
  doi: 10.1007/s00737-003-0172-8
– volume: 77
  start-page: 434
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0040
  article-title: Anticipatory reward processing in addicted populations: A focus on the monetary incentive delay task
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2014.08.020
– volume: 155
  start-page: 310
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0470
  article-title: Reduced serotonin transporter binding in binge eating women
  publication-title: Psychopharmacology
  doi: 10.1007/s002130100716
– volume: 3
  start-page: 1273
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0685
  article-title: Subjective feeling of appetite modulates brain activity: An fMRI study
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2006.04.216
– volume: 25
  start-page: 705
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0085
  article-title: Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets
  publication-title: Behavioural Pharmacology
  doi: 10.1097/FBP.0000000000000058
– volume: 44
  start-page: 103
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0710
  article-title: At first sight: How do restrained eaters evaluate high-fat palatable foods?
  publication-title: Appetite
  doi: 10.1016/j.appet.2004.08.001
– volume: 226
  start-page: 189
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0825
  article-title: A review of the abuse potential assessment of atomoxetine: A nonstimulant medication for attention-deficit/hyperactivity disorder
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-013-2986-z
– volume: 21
  start-page: RC159
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0450
  article-title: Anticipation of increasing monetary reward selectively recruits nucleus accumbens
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.21-16-j0002.2001
– volume: 159
  start-page: 26
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0460
  article-title: Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users
  publication-title: Drug and Alcohol Dependence
  doi: 10.1016/j.drugalcdep.2015.10.029
– volume: 179
  start-page: 4
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0440
  article-title: Ionotropic and metabotropic glutamate receptor structure and pharmacology
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-2200-z
– volume: 64
  start-page: 801
  year: 1995
  ident: 10.1016/j.pharmthera.2017.08.002_bb0045
  article-title: Afferent connections of the caudolateral orbitofrontal cortex taste area of the primate
  publication-title: Neuroscience
  doi: 10.1016/0306-4522(94)00449-F
– volume: 121
  start-page: 20
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0645
  article-title: Efficacy of rimonabant in obese patients with binge eating disorder
  publication-title: Experimental and Clinical Endocrinology & Diabetes
– volume: 18
  start-page: 794
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0070
  article-title: Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder
  publication-title: European Neuropsychopharmacology
  doi: 10.1016/j.euroneuro.2008.05.004
– year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0445
  article-title: Stress-induced eating in women with binge-eating disorder and obesity
  publication-title: Biological Psychology
– volume: 65
  start-page: 209
  year: 2002
  ident: 10.1016/j.pharmthera.2017.08.002_bb0210
  article-title: GABAB receptor agonists for the treatment of drug addiction: A review of recent findings
  publication-title: Drug and Alcohol Dependence
  doi: 10.1016/S0376-8716(01)00163-6
– volume: 60
  start-page: 1181
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0125
  article-title: Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of the rat trace amine receptor
  publication-title: Molecular Pharmacology
  doi: 10.1124/mol.60.6.1181
– volume: 12
  start-page: 91
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0150
  article-title: Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: Preclinical and clinical data
  publication-title: CNS Drug Reviews
  doi: 10.1111/j.1527-3458.2006.00091.x
– volume: 134
  start-page: 807
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0220
  article-title: Emotion-based dispositions to rash action: Positive and negative urgency
  publication-title: Psychological Bulletin
  doi: 10.1037/a0013341
– volume: 107
  start-page: 1
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0640
  article-title: Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: Lack of withdrawal-like responses
  publication-title: Physiology & Behavior
  doi: 10.1016/j.physbeh.2012.06.017
– volume: 29
  start-page: 565
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0400
  article-title: Neural mechanisms of addiction: The role of reward-related learning and memory
  publication-title: Annual Review of Neuroscience (Palo Alto, CA)
  doi: 10.1146/annurev.neuro.29.051605.113009
– volume: 14
  start-page: 583
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0595
  article-title: The cannabinoid CB1 antagonists SR141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats
  publication-title: Behavioural Pharmacology
  doi: 10.1097/00008877-200312000-00002
– volume: 341
  start-page: 39
  year: 1998
  ident: 10.1016/j.pharmthera.2017.08.002_bb0285
  article-title: Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
  publication-title: European Journal of Pharmacology
  doi: 10.1016/S0014-2999(97)01442-8
– volume: 141
  start-page: 283
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0915
  article-title: The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence
  publication-title: Pharmacology & Therapeutics
  doi: 10.1016/j.pharmthera.2013.10.011
– volume: 86
  start-page: 176
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0120
  article-title: Baclofen reduces fat intake under binge-type conditions
  publication-title: Physiology & Behavior
  doi: 10.1016/j.physbeh.2005.07.020
– volume: 10
  start-page: 2275
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0760
  article-title: Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
  publication-title: Neuropsychiatric Disease and Treatment
– volume: 60
  start-page: 206
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0830
  article-title: Escalation in high fat intake in a binge eating model differentially engages dopamine neurons of the ventral tegmental area and requires ghrelin signaling
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2015.06.018
– volume: 140
  start-page: 790
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0720
  article-title: Anandamide and vanilloid TRPV1 receptors
  publication-title: British Journal of Pharmacology
  doi: 10.1038/sj.bjp.0705467
– volume: 40
  start-page: 1163
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0775
  article-title: The uncompetitive N-methyl-d-aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: Role of the nucleus accumbens shell
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.299
– volume: 24
  start-page: 223
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0590
  article-title: Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder
  publication-title: European Eating Disorders Review
  doi: 10.1002/erv.2418
– volume: 16
  start-page: 1042
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0370
  article-title: The fat mass and obesity associated gene (FTO) regulates activity of the dopaminergic midbrain circuitry
  publication-title: Nature Neuroscience
  doi: 10.1038/nn.3449
– volume: 25
  start-page: 777
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0660
  article-title: Hedonic hot spot in nucleus accumbens shell: Where do mu opioids cause increased hedonic impact of sweetness?
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.2329-05.2005
– volume: 30
  start-page: 619
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0105
  article-title: Functional imaging of neural responses to expectancy and experience of monetary gains and losses
  publication-title: Neuron
  doi: 10.1016/S0896-6273(01)00303-8
– volume: 33
  start-page: 1028
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0700
  article-title: Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301487
– volume: 9
  start-page: 299
  year: 2017
  ident: 10.1016/j.pharmthera.2017.08.002_bb0630
  article-title: The efficacy of psychological therapies in reducing weight and binge eating in people with bulimia nervosa and binge eating disorder who are overweight or obese—A critical synthesis and meta-analyses
  publication-title: Nutrients
  doi: 10.3390/nu9030299
– volume: 141B
  start-page: 7
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0605
  article-title: Association of a functional serotonin transporter gene polymorphism with binge eating disorder
  publication-title: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
  doi: 10.1002/ajmg.b.30232
– volume: 23
  start-page: 2882
  year: 2003
  ident: 10.1016/j.pharmthera.2017.08.002_bb0905
  article-title: Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.23-07-02882.2003
– volume: 110
  start-page: 86
  year: 1991
  ident: 10.1016/j.pharmthera.2017.08.002_bb0360
  article-title: Binge eating as escape from self-awareness
  publication-title: Psychological Bulletin
  doi: 10.1037/0033-2909.110.1.86
– volume: 311
  start-page: 861
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0165
  article-title: Neurochemical modulation of response inhibition and probabilistic learning in humans
  publication-title: Science
  doi: 10.1126/science.1121218
– volume: 23
  start-page: 616
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0195
  article-title: Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study
  publication-title: Behavioural Pharmacology
  doi: 10.1097/FBP.0b013e328357bd62
– volume: 18
  start-page: 9996
  year: 1998
  ident: 10.1016/j.pharmthera.2017.08.002_bb0670
  article-title: Neurons containing hypocretin (orexin) project to multiple neuronal systems
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.18-23-09996.1998
– volume: 17
  start-page: 1220
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0235
  article-title: Dopamine for wanting and opioids for liking: A comparison of obese adults with and without binge eating
  publication-title: Obesity
  doi: 10.1038/oby.2009.52
– volume: 12
  start-page: 3239
  year: 2000
  ident: 10.1016/j.pharmthera.2017.08.002_bb0320
  article-title: Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
  publication-title: The European Journal of Neuroscience
  doi: 10.1046/j.1460-9568.2000.00217.x
– volume: 30
  start-page: 662
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0345
  article-title: Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model
  publication-title: Journal of Psychopharmacology
  doi: 10.1177/0269881116647506
– volume: 31
  start-page: 3249
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0600
  article-title: Induction of hyperphagia and carbohydrate intake by μ-opioid receptor stimulation in circumscribed region of frontal cortex
  publication-title: The Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.2050-10.2011
– volume: 32
  start-page: 451
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0735
  article-title: Connectomics of orexin-producing neurons: Interface of systems of emotion, energy homeostasis and arousal
  publication-title: Trends in Pharmacological Sciences
  doi: 10.1016/j.tips.2011.03.007
– volume: 72
  start-page: 341
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0465
  article-title: The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology
  publication-title: Progress in Neurobiology
  doi: 10.1016/j.pneurobio.2004.03.006
– volume: 253
  start-page: 858
  year: 1990
  ident: 10.1016/j.pharmthera.2017.08.002_bb0410
  article-title: Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1016/S0022-3565(25)13057-7
– volume: 68
  start-page: 390
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0575
  article-title: Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial
  publication-title: The Journal of Clinical Psychiatry
  doi: 10.4088/JCP.v68n0306
– volume: 205
  start-page: 489
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0650
  article-title: Acute effects of morphine on distinct forms of impulsive behavior in rats
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1558-8
– volume: 23
  start-page: 1486
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0665
  article-title: Images of desire: Food-craving activation during fMRI
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2004.08.023
– volume: 20
  start-page: 557
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0025
  article-title: Neurobiological features of binge eating disorder
  publication-title: CNS Spectrums
  doi: 10.1017/S1092852915000814
– volume: 73
  start-page: 877
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0030
  article-title: Monetary reward processing in obese individuals with and without binge eating disorder
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2013.01.014
– volume: 2
  start-page: 367
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0035
  article-title: Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.20068
– volume: 111
  start-page: E1648
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0615
  article-title: Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
  publication-title: Proceedings of the National Academy of Sciences
  doi: 10.1073/pnas.1315542111
– volume: 18
  start-page: 1710
  year: 2010
  ident: 10.1016/j.pharmthera.2017.08.002_bb0225
  article-title: A model of binge-like eating behavior in mice that does not require food deprivation or stress
  publication-title: Obesity
  doi: 10.1038/oby.2010.46
– volume: 42
  start-page: 1511
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0835
  article-title: Activation of ventral tegmental area 5-HT2C receptors reduces incentive motivation
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2016.264
– volume: 63
  start-page: 223
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0435
  article-title: The neurobiological basis of binge-eating disorder
  publication-title: Neuroscience and Biobehavioral Reviews
  doi: 10.1016/j.neubiorev.2016.01.013
– volume: 65
  start-page: 654
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0755
  article-title: Binge-eating disorder: Reward sensitivity and brain activation to images of food
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2008.09.028
– volume: 419
  start-page: 163
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0545
  article-title: Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice
  publication-title: European Journal of Pharmacology
  doi: 10.1016/S0014-2999(01)00968-2
– volume: 92
  start-page: 528
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0925
  article-title: Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions
  publication-title: Pharmacology, Biochemistry, and Behavior
  doi: 10.1016/j.pbb.2009.02.002
– volume: 19
  start-page: 2289
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0880
  article-title: Syntheses of novel high affinity ligands for opioid receptors
  publication-title: Bioorganic & Medicinal Chemistry Letters
  doi: 10.1016/j.bmcl.2009.02.078
– volume: 19
  start-page: 849
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0250
  article-title: The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food
  publication-title: Addiction Biology
  doi: 10.1111/adb.12056
– volume: 14
  start-page: 383
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0635
  article-title: NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease
  publication-title: Nature Reviews. Neuroscience
  doi: 10.1038/nrn3504
– volume: 19
  start-page: 975
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0725
  article-title: Evidence for a compulsive-like behavior in rats exposed to alternate access to highly preferred palatable food
  publication-title: Addiction Biology
  doi: 10.1111/adb.12065
– volume: 143
  start-page: 253
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0395
  article-title: Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders
  publication-title: Pharmacology & Therapeutics
  doi: 10.1016/j.pharmthera.2014.03.005
– volume: 42
  start-page: 1169
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0520
  article-title: Dopamine and opioid neurotransmission in behavioral addictions: A comparative PET study in pathological gambling and binge eating
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2016.265
– volume: 154
  start-page: 406
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0620
  article-title: Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats
  publication-title: British Journal of Pharmacology
  doi: 10.1038/bjp.2008.3
– volume: 120
  start-page: 891
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0860
  article-title: Epigenetic dysregulation of the dopamine system in diet induced obesity
  publication-title: Journal of Neurochemistry
  doi: 10.1111/j.1471-4159.2012.07649.x
– volume: 34
  start-page: 172
  year: 2010
  ident: 10.1016/j.pharmthera.2017.08.002_bb0090
  article-title: Acute stress and food-related reward activation in the brain during food choice during eating in the absence of hunger
  publication-title: International Journal of Obesity
  doi: 10.1038/ijo.2009.221
– volume: 169
  start-page: 820
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0750
  article-title: Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats
  publication-title: British Journal of Pharmacology
  doi: 10.1111/bph.12014
– volume: 12
  start-page: 13
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0170
  article-title: The use of lisdexamfetamine dimesylate for the treatment of ADHD
  publication-title: Expert Review of Neurotherapeutics
  doi: 10.1586/ern.11.175
– volume: 207
  start-page: 100
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0230
  article-title: Influence of negative affect on choice behavior in individuals with binge eating pathology
  publication-title: Psychiatry Research
  doi: 10.1016/j.psychres.2012.10.016
– volume: 87
  start-page: 1
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0355
  article-title: CNS stimulants
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2014.09.025
– volume: 224
  start-page: 501
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0160
  article-title: Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-012-2778-x
– volume: 37
  start-page: 2643
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0290
  article-title: Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2012.128
– volume: 26
  start-page: 299
  year: 2002
  ident: 10.1016/j.pharmthera.2017.08.002_bb0240
  article-title: Binge eating disorder: A review
  publication-title: International Journal of Obesity
  doi: 10.1038/sj.ijo.0801949
– volume: 10
  start-page: 260
  year: 2004
  ident: 10.1016/j.pharmthera.2017.08.002_bb0565
  article-title: The neural substrates of reward processing in humans: The modern role of FMRI
  publication-title: The Neuroscientist
  doi: 10.1177/1073858404263526
– volume: 50
  start-page: 639
  year: 2010
  ident: 10.1016/j.pharmthera.2017.08.002_bb0740
  article-title: Regional grey matter volume abnormalities in bulimia nervosa and binge-eating disorder
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2009.12.063
– volume: 13
  start-page: 188
  issue: 10
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0505
  article-title: Acute stressors reduce neural inhibition to food cues and increase eating among binge eating disorder symptomatic women
  publication-title: Frontiers in Behavioral Neuroscience
– volume: 191
  start-page: 391
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0055
  article-title: The debate over dopamine's role in reward: The case for incentive salience
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-006-0578-x
– volume: 57
  start-page: 659
  year: 2000
  ident: 10.1016/j.pharmthera.2017.08.002_bb0265
  article-title: The natural course of bulimia nervosa and binge eating disorder in young women
  publication-title: Archives of General Psychiatry
  doi: 10.1001/archpsyc.57.7.659
– volume: 204
  start-page: 113
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0180
  article-title: A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: Effect of sibutramine, fluoxetine, topiramate and midazolam
  publication-title: Pyschopharmacology
  doi: 10.1007/s00213-008-1442-y
– volume: 39
  start-page: 2309
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0790
  article-title: Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.91
– volume: 41
  start-page: 200
  year: 2001
  ident: 10.1016/j.pharmthera.2017.08.002_bb0840
  article-title: Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors
  publication-title: Neuropharmacology
  doi: 10.1016/S0028-3908(01)00063-6
– volume: 26
  start-page: 2331
  year: 2005
  ident: 10.1016/j.pharmthera.2017.08.002_bb0895
  article-title: Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity
  publication-title: Peptides
  doi: 10.1016/j.peptides.2005.03.042
– volume: 33
  start-page: 2135
  year: 2012
  ident: 10.1016/j.pharmthera.2017.08.002_bb0890
  article-title: Diagnosing different binge-eating disorders based on reward-related brain activation patterns
  publication-title: Human Brain Mapping
  doi: 10.1002/hbm.21345
– volume: 365
  start-page: 61
  year: 1993
  ident: 10.1016/j.pharmthera.2017.08.002_bb0610
  article-title: Molecular characterization of a peripheral receptor for cannabinoids
  publication-title: Nature
  doi: 10.1038/365061a0
– volume: 368
  start-page: 20120380
  issue: 1615
  year: 2013
  ident: 10.1016/j.pharmthera.2017.08.002_bb0065
  article-title: Genetics of impulsive behavior
  publication-title: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
  doi: 10.1098/rstb.2012.0380
– volume: 11
  start-page: 1393
  year: 2016
  ident: 10.1016/j.pharmthera.2017.08.002_bb0770
  article-title: Neural signature of food reward processing in bulimic-type eating disorders
  publication-title: Social Cognitive and Affective Neuroscience
  doi: 10.1093/scan/nsw049
– volume: 19
  start-page: 652
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0075
  article-title: Opioid system in the medial prefrontal cortex mediates binge-like eating
  publication-title: Addiction Biology
  doi: 10.1111/adb.12033
– volume: 40
  start-page: 687
  year: 2007
  ident: 10.1016/j.pharmthera.2017.08.002_bb0115
  article-title: Baclofen for binge eating: An open-label trial
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.20434
– volume: 324
  start-page: 948
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0490
  article-title: Trace amine-associated receptor 1 modulates dopaminergic activity
  publication-title: The Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1124/jpet.107.132647
– volume: 75
  start-page: 487
  year: 2014
  ident: 10.1016/j.pharmthera.2017.08.002_bb0365
  article-title: Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2013.09.005
– volume: 90
  start-page: 928
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0560
  article-title: Differential functional magnetic resonance imaging response to food pictures in successful weight-loss maintainers relative to normal-weight and obese controls
  publication-title: The American Journal of Clinical Nutrition
  doi: 10.3945/ajcn.2009.27924
– volume: 32
  start-page: 1599
  year: 2008
  ident: 10.1016/j.pharmthera.2017.08.002_bb0480
  article-title: A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorder
  publication-title: Progress in Neuro-Psychopharmacology & Biological Psychiatry
  doi: 10.1016/j.pnpbp.2008.06.005
– volume: 60
  start-page: 4
  year: 2017
  ident: 10.1016/j.pharmthera.2017.08.002_bb0815
  article-title: Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and n-acylethanolamine acid amidase inhibitors
  publication-title: Journal of Medicinal Chemistry
  doi: 10.1021/acs.jmedchem.6b00538
– volume: 368
  start-page: 1660
  year: 2006
  ident: 10.1016/j.pharmthera.2017.08.002_bb0745
  article-title: Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69571-8
– volume: 19
  start-page: 1601
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0865
  article-title: Enhanced striatal dopamine release during food stimulation in binge eating disorder
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2011.27
– volume: 44
  start-page: 585
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0080
  article-title: Reward abnormalities among women with full and subthreshold bulimia nervosa: A functional magnetic resonance imaging study
  publication-title: The International Journal of Eating Disorders
  doi: 10.1002/eat.20869
– volume: 61
  start-page: 1070
  year: 2011
  ident: 10.1016/j.pharmthera.2017.08.002_bb0765
  article-title: Endocannabinoid-mediated synaptic plasticity and addiction related behavior
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.05.034
– volume: 1
  start-page: 51
  year: 2009
  ident: 10.1016/j.pharmthera.2017.08.002_bb0540
  article-title: Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa
  publication-title: Archives of General Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.504
– volume: 20
  start-page: 566
  year: 2015
  ident: 10.1016/j.pharmthera.2017.08.002_bb0855
  article-title: Cognitive biases in binge eating disorder: The hijacking of decision making
  publication-title: CNS Spectrums
  doi: 10.1017/S1092852915000681
SSID ssj0004402
Score 2.416531
SecondaryResourceType review_article
Snippet Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2–5% of the general adult population. Nonetheless, its pathophysiology is...
Binge-eating disorder (BED) is the most prevalent eating disorder with estimates of 2-5% of the general adult population. Nonetheless, its pathophysiology is...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 15
SubjectTerms Animals
Binge-eating disorder
Binge-Eating Disorder - diagnostic imaging
Binge-Eating Disorder - drug therapy
Binge-Eating Disorder - psychology
Brain - diagnostic imaging
Brain - drug effects
Compulsivity
Disease Models, Animal
Humans
Impulsivity
Neurobiology
Pharmacotherapy
Reward
Title Binge-eating disorder: Clinical and therapeutic advances
URI https://dx.doi.org/10.1016/j.pharmthera.2017.08.002
https://www.ncbi.nlm.nih.gov/pubmed/28830840
https://www.proquest.com/docview/1931713981
Volume 182
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6KXryIb-ujrCCejE2ym2SrpyqWqigFW_C27CMRRWKx9dCLv92Z7MbqQRC8JWGXLLOTnZnMN98QcqjyMNFM8MCCfQm40GGgjCog5jE2LngBJh0zurd3aX_Erx-Shwa5qGthEFbpz353plentX_S9tJsj5-e2vfgrLAsTkQESoo85VjBzjPU8pOPOcyD8wp3iIMDHO3RPA7jNUZ66KrQCUFe2YkDVv5mon5zQStT1Fshy96HpF23zFXSyMs1cjRwJNSzYzqc11RNjukRHczpqWfrRJzjn7wAfcXykVrPvnlKPUPoC1Wlpd_KsqiHCUw2yKh3ObzoB75_QmBYxqdBmhuINzqs4EbzjlAxNwWYfGvwUmWi0FFUhFqo1EKUF1sQnjKYuQOh2cREbJMslK9lvk1oajNtrUlClhmuteiEBkMPlWrGWKqTJslqkUnjycWxx8WLrFFkz3IubInCltj-MoybJPqaOXYEG3-Yc1bvivyhLBLswB9mH9QbKeFbwgSJKvPX94kEZzaCoL0joibZcjv8tSbsyhxCNLzzr3fvkiW4Ew72vUcWpm_v-T54NVPdqtS2RRa7Vzf9u08RWvdr
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9tAEB7RcGgvqEAfaXlspYoTJrZ3ba_hBBFRKAEhNZFyW-3DrkDIRE04cOG3M2OvSXtAQuJm2bvyavYxMzvffAPwUxdhYrgUgUP9EghpwkBbXaLPY11cihJVOkV0Ly7T4UT8mibTFei3uTAEq_Rnf3Om16e1f9Pz0uzNrq97v9FY4VmcyAgXKfGUv4NVgduXyhgcPC5xHkLUwENqHVBzD-dpQF4z4oeuM50I5ZUdNMjKl3TUSzZorYsGH2HNG5HsuBnnOqwU1QbsXTUs1A_7bLxMqprvsz12teSnftgEeUJXeQEZi9Uf5jz95iHzFKG3TFeO_ZOXxTxOYP4JJoPTcX8Y-AIKgeWZWARpYdHhyHkprBG51LGwJep8Z-lRZ7I0UVSGRurUoZsXO5Gl2lLoDoXmEhvxz9Cp7qriK7DUZcY5m4Q8s8IYmYeWfA-dGs55apIuZK3IlPXs4lTk4la1MLIbtRS2ImErqn8Zxl2InnvOGoaNV_Q5amdF_bdaFCqCV_T-0U6kws1EERJdFXf3c4XWbIReey6jLnxpZvh5TFSWOUR3-Nub_r0L74fji5EanV2ef4cP-EU2GPAt6Cz-3hfbaOIszE69hJ8AtEX4-Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Binge-eating+disorder%3A+Clinical+and+therapeutic+advances&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Hutson%2C+Peter+H.&rft.au=Balodis%2C+Iris+M.&rft.au=Potenza%2C+Marc+N.&rft.date=2018-02-01&rft.issn=0163-7258&rft.volume=182&rft.spage=15&rft.epage=27&rft_id=info:doi/10.1016%2Fj.pharmthera.2017.08.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_pharmthera_2017_08_002
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-7258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-7258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-7258&client=summon